Tailored interventions to address determinants of practice
Open accessAbstract
BACKGROUND: Tailored intervention strategies are frequently recommended among approaches to the implementation of improvement in health professional performance. Attempts to change the behaviour of health professionals may be impeded by a variety of different barriers, obstacles, or factors (which we collectively refer to as determinants of practice). Change may be more likely if implementation strategies are specifically chosen to address these determinants. OBJECTIVES: To determine whether tailored intervention strategies are effective in improving professional practice and healthcare outcomes. We compared interventions tailored to address the identified determinants of practice with either no intervention or interventions not tailored to the determinants. SEARCH METHODS: We conducted searches of The Cochrane Library, MEDLINE, EMBASE, PubMed, CINAHL, and the British Nursing Index to May 2014. We conducted a final search in December 2014 (in MEDLINE only) for more recently published trials. We conducted searches of the metaRegister of Controlled Trials (mRCT) in March 2013. We also handsearched two journals. SELECTION CRITERIA: Cluster-randomised controlled trials (RCTs) of interventions tailored to address prospectively identified determinants of practice, which reported objectively measured professional practice or healthcare outcomes, and where at least one group received an intervention designed to address prospectively identified determinants of practice. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed quality and extracted data. We undertook qualitative and quantitative analyses, the quantitative analysis including two elements: we carried out 1) meta-regression analyses to compare interventions tailored to address identified determinants with either no interventions or an intervention(s) not tailored to the determinants, and 2) heterogeneity analyses to investigate sources of differences in the effectiveness of interventions. These included the effects of: risk of bias, use of a theory when developing the intervention, whether adjustment was made for local factors, and number of domains addressed with the determinants identified. MAIN RESULTS: We added nine studies to this review to bring the total number of included studies to 32 comparing an intervention tailored to address identified determinants of practice to no intervention or an intervention(s) not tailored to the determinants. The outcome was implementation of recommended practice, e.g. clinical practice guideline recommendations. Fifteen studies provided enough data to be included in the quantitative analysis. The pooled odds ratio was 1.56 (95% confidence interval (CI) 1.27 to 1.93, P value < 0.001). The 17 studies not included in the meta-analysis had findings showing variable effectiveness consistent with the findings of the meta-regression. AUTHORS' CONCLUSIONS: Despite the increase in the number of new studies identified, our overall finding is similar to that of the previous review. Tailored implementation can be effective, but the effect is variable and tends to be small to moderate. The number of studies remains small and more research is needed, including trials comparing tailored interventions to no or other interventions, but also studies to develop and investigate the components of tailoring (identification of the most important determinants, selecting interventions to address the determinants). Currently available studies have used different methods to identify determinants of practice and different approaches to selecting interventions to address the determinants. It is not yet clear how best to tailor interventions and therefore not clear what the effect of an optimally tailored intervention would be.
Verified 2026-10-06 · 1 reference not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
This updated Cochrane review found that tailored implementation interventions can improve professional practice, but effects are variable and small to moderate. Across 15 studies in meta-regression, the pooled odds ratio was 1.56 (95% CI 1.27 to 1.93, P < 0.001).
Key findings
- The review included 32 cluster-randomised trials comparing tailored interventions with no intervention or non-tailored interventions; 15 studies contributed to the meta-regression, with a pooled OR of 1.56 (95% CI 1.27 to 1.93, P < 0.001).
- In separate comparisons, tailored versus no intervention had a pooled OR of 1.36 (95% CI 0.92 to 1.99, P = 0.099) across 7 studies, while tailored versus non-tailored intervention had a pooled OR of 1.79 (95% CI 1.06 to 3.01, P = 0.033) across 8 studies; removing Beeckman 2013 gave OR 1.48 (95% CI 1.24 to 1.75, P = 0.002).
- The 17 studies not included in the meta-analysis showed variable effectiveness consistent with the meta-regression; GRADE certainty was moderate, and there were insufficient data to assess healthcare outcomes, costs, or adverse effects.
- Heterogeneity analyses found no association between effectiveness and risk of bias, use of theory, adjustment for local factors, or number of determinant domains addressed.
Methods
- Updated Cochrane review of cluster-RCTs with at least two control and two intervention sites, including healthcare professionals responsible for patient care; tailored interventions were defined as strategies planned after prospective identification of determinants of practice.
- Searches covered The Cochrane Library, MEDLINE, EMBASE, PubMed, CINAHL, and the British Nursing Index to May 2014, with a final MEDLINE search in December 2014; 9403 unique citations were screened and 32 studies included.
- Two review authors independently assessed quality and extracted data; meta-regression combined adjusted odds ratios with baseline odds ratios as a covariate, and heterogeneity was investigated using the I² residual statistic.
Limitations
- The paper states that the number of studies remains small, methods of tailoring are not well developed or described, it is unclear which element of tailored strategies explains effectiveness, and cost-effectiveness is uncertain.
- The paper states that only 15 of 32 trials could be included in the meta-regression, limiting power to detect study attributes explaining variation, and that evidence is limited for low-income countries and disadvantaged groups.
- Evident from the text: risk of bias was high in 4 studies and unclear in 21, most control groups received only guidelines or educational materials, and no included studies provided sufficient evidence on healthcare outcomes, costs, or adverse effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 194 cited sources checked · 0 supported · 0 flagged
- Findingown data§ Background
No reviews other than earlier versions of this review have evaluated the effects of tailored implementation strategies on professional performance.
“We have not identified any reviews evaluating the effects of tailored implementation strategies on professional performance other than the earlier versions of this review”
Quote in the paperSubstantial claim - Findingown data§ Methods
Five studies included in the analysis reported either an estimate of the ICC or reported data for each cluster, allowing the ICC to be estimated.
“Five studies included in the analysis reported either an estimate of the ICC or reported data for each cluster, allowing the ICC to be estimated.”
Quote in the paperSubstantial claim - Findingown data§ Results
For the seven studies that received no control intervention, the pooled odds ratio was 1.36 (95% CI 0.92 to 1.99, P = 0.099).
“Of these, seven were suitable for inclusion in a meta‐regression, and the pooled odds ratio for the seven studies that received no control intervention was 1.36 (95% CI 0.92 to 1.99, P value = 0.099) (Avorn 1992; Callahan 1994; Flottorp 2002; Looijmans 2010; Murphy 2009; Scott 2013; Schouten 2007).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Findingcitation§ Data synthesis
One study delivered a group lecture and distributed the standard protocol to the control group.
“One study delivered a group lecture and distributed the standard protocol to the control group (Beeckman 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Beeckman 2013 source
Not checked in the free run.
- Findingown data§ Abstract
Fifteen studies provided enough data to be included in the quantitative analysis.
“Fifteen studies provided enough data to be included in the quantitative analysis.”
Quote in the paperSubstantial claim
- Findingown data§ Results
All included studies were cluster-randomised trials.
“All included studies were cluster‐randomised trials (Characteristics of included studies).”
Quote in the paperNot a substantial claim - Findingnone given§ Authors' conclusions
The number of studies remains small.
“The number of studies remains small”
Quote in the paperSubstantial claim - Findingown data§ Results
When combined using meta-regression techniques and adjusting for baseline odds ratios, the pooled odds ratio was 1.56 (95% CI 1.27 to 1.93, P < 0.001).
“When combined using meta‐regression techniques and adjusting for baseline odds ratios, the pooled odds ratio was 1.56 (95% confidence interval (CI) 1.27 to 1.93, P value < 0.001).”
Quote in the paperSubstantial claim - Findingown data§ Results
In sensitivity analyses, for the eight studies with no intervention control, the odds ratio was 1.30 (95% CI 0.78 to 2.15, P = 0.243).
“For the eight studies where the control group was a non‐tailored intervention, the OR was 1.63 (95% CI 1.11 to 2.40, P value = 0.020), and for the eight studies where the control group received no intervention the OR was 1.30 (95% CI 0.78 to 2.15, P value = 0.243).”
Quote in the paperNot a substantial claim - Findingown data§ Methods
None of the studies described problems of drop-outs at the cluster level during the trial period.
“None of the studies described problems of drop‐outs at this level during the trial period.”
Quote in the paperNot a substantial claim - Findingnone given§ Results
The 17 studies not included in the meta-regression had findings showing variable effectiveness consistent with the findings of the meta-regression.
“The 17 studies not included had findings showing variable effectiveness consistent with the findings of the meta‐regression.”
Quote in the paperNot a substantial claim - Findingown data§ Results
In sensitivity analyses, for the eight studies with a non-tailored control intervention, the odds ratio was 1.63 (95% CI 1.11 to 2.40, P = 0.020).
“For the eight studies where the control group was a non‐tailored intervention, the OR was 1.63 (95% CI 1.11 to 2.40, P value = 0.020), and for the eight studies where the control group received no intervention the OR was 1.30 (95% CI 0.78 to 2.15, P value = 0.243).”
Quote in the paperNot a substantial claim - Findingown data§ Results
We included 32 studies.
“Of these, we included 32.”
Quote in the paperSubstantial claim - Findingown data§ Results
In all but one of the trials comparing tailored to non-tailored interventions, the non-tailored intervention consisted of the dissemination of written educational materials or guidelines.
“In all but one of these trials, the non‐tailored intervention consisted of the dissemination of written educational materials or guidelines.”
Quote in the paperNot a substantial claim - Findingcitation§ Background
Several new studies of tailored intervention strategies have been published since the last revision of this review.
“Since the publication of the last revision of this review (Baker 2010), several new studies of tailored intervention strategies have been published.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Baker 2010 source
Not checked in the free run.
- Findingown data§ Abstract
The pooled odds ratio was 1.56 (95% confidence interval 1.27 to 1.93, P value < 0.001).
“The pooled odds ratio was 1.56 (95% confidence interval (CI) 1.27 to 1.93, P value < 0.001).”
Quote in the paperSubstantial claim - Findingown data§ Results
For the eight studies with a non-tailored control intervention included in meta-regression, the pooled odds ratio was 1.79 (95% CI 1.06 to 3.01, P = 0.033).
“Eight of these were included in a meta‐regression; the pooled odds ratio was 1.79 (95% CI 1.06 to 3.01, P value = 0.033) (Baker 2001; Beeckman 2013; Cheater 2006; Coenen 2004; Evans 1997; Fretheim 2006; Leviton 1999; Simon 2005).”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingown data§ Discussion
In the subsidiary comparisons, the effect of tailoring appeared to be less in comparison with no intervention than with non-tailored interventions.
“In the subsidiary comparisons, the effect of tailoring appeared to be less in comparison with no intervention than with non‐tailored interventions.”
Quote in the paperNot a substantial claim - Findingown data§ Results
Removing Beeckman 2013 from the meta-regression gave a pooled odds ratio of 1.48 (95% CI 1.24 to 1.75, P = 0.002).
“Removing this study from the meta‐regression gave a pooled odds ratio of 1.48 (95% CI 1.24 to 1.75, P value = 0.002) (plots for these two comparisons are shown in Figure 5 and Figure 6).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Beeckman 2013 source
Not checked in the free run.
- Findingown data§ Results
The odds ratios at follow-up, adjusted for clustering, ranged from 1.08 to 10.59.
“The odds ratios at follow‐up, adjusted for clustering, ranged from 1.08 to 10.59.”
Quote in the paperNot a substantial claim - Findingown data§ Data synthesis
Of the eight studies that received a non-tailored intervention, seven received relevant guidelines or educational material only.
“Of the eight studies that received a non‐tailored intervention, seven received relevant guidelines or educational material only.”
Quote in the paperNot a substantial claim - Findingnone given§ Plain language summary
There is no evidence about the cost-effectiveness of tailored interventions compared to other interventions to change professional practice.
“In addition, there is no evidence about the cost‐effectiveness of tailored interventions compared to other interventions to change professional practice.”
Quote in the paperSubstantial claim - Findingown data
In all but one study, the control intervention was limited to the dissemination of educational materials or guidelines.
“but in all but one study the control intervention was limited to the dissemination of educational materials or guidelines.”
Quote in the paperSubstantial claim - Findingreasoning
The methods used to identify determinants and to select interventions to address them, including the rationale for intervention selection, varied between studies.
“The methods used to identify determinants and to select interventions to address them, including the rationale underpinning the approach to intervention selection, varied between studies.”
Quote in the paperSubstantial claim - Findingnone given
Evidence on the applicability of tailored implementation to low-income countries and with disadvantaged groups is limited.
“Evidence on the applicability of the method to low‐income countries and with disadvantaged groups is also limited.”
Quote in the paperSubstantial claim - Findingreasoning
The included studies did not suggest that a generally accepted method for selecting strategies to address determinants had emerged.
“they did not suggest that a generally accepted method had emerged”
Quote in the paperSubstantial claim - Findingnone given§ Authors' conclusions
The cost-effectiveness of tailored implementation in comparison with other implementation interventions is uncertain.
“Furthermore, the cost‐effectiveness of tailored implementation in comparison with other implementation interventions is uncertain.”
Quote in the paperSubstantial claim - Findingnone given§ Certainty of the evidence
Fifteen studies could be included in the meta-regression analysis in this update.
“Fifteen studies could be included in the meta‐regression analysis in this update.”
Quote in the paperNot a substantial claim - Findingown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
Level of tailoring was not predictive in the meta-regression analysis.
“Level of tailoring In analysis Not predictive Remove”
Quote in the paperSubstantial claim - Findingnone given
The studies in the review did not investigate whether identified determinants had been overcome by the chosen interventions other than through assessment of changes in professional behaviour or health outcomes.
“The studies in our review also did not investigate whether identified determinants had been overcome by the chosen interventions other than through assessment of changes in professional behaviour or health outcomes.”
Quote in the paperSubstantial claim - Findingown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The presence or absence of administrative constraints was not predictive in the meta-regression analysis.
“The presence or absence of administrative constraints In analysis Not predictive; the presence of administrative constraints may not be consistently reported in studies Remove”
Quote in the paperNot a substantial claim - Findingown data
The review shows that tailored strategies can be effective.
“Therefore, our review shows that tailored strategies can be effective”
- Also stated in: § Agreements and disagreements with other studies and reviews · plain
“Our findings concur with these reviews in showing that tailored strategies can be effective, but that the methods of tailoring are not yet well developed and are not described in detail in published studies.”
Quote in the paperSubstantial claim - Also stated in: § Agreements and disagreements with other studies and reviews · plain
- Findingown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
Rigour of determinants analysis was not predictive in the meta-regression analysis.
“Rigour of determinants analysis In analysis Not predictive; it is difficult to assess the quality of determinants analyses in studies since there is limited evidence on which methods should be used with different topics and settings Remove”
Quote in the paperSubstantial claim - Findingreasoning§ Certainty of the evidence
The reasons for the moderate certainty of evidence remain the variable risk of bias of the included studies and the inconsistent results.
“The reasons for this remain the variable risk of bias of the included studies and the inconsistent results.”
Quote in the paperSubstantial claim - Findingreasoning
The studies included in the review do not enable any assessment of the costs of tailored strategies.
“It should be pointed out that the studies included in this review do not enable any assessment of the costs of tailored strategies.”
Quote in the paperSubstantial claim - Findingreasoning§ Certainty of the evidence
Applying GRADE, the certainty of evidence is still moderate.
“Nevertheless, applying the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system (GRADE Working Group 2004), the certainty of evidence is still moderate (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites GRADE Working Group 2004 source
Not checked in the free run.
- Findingreasoning§ Certainty of the evidence
Interventions tailored to address identified barriers are probably more likely to improve professional practice than no intervention or the dissemination of guidelines alone.
“It is possible to have reasonable confidence that tailored implementation strategies are more likely to lead to improved performance than the dissemination of guidelines alone”
- Also stated in: § Authors' conclusions · hedged
“Interventions tailored to address identified barriers are probably more likely to improve professional practice than no intervention or the dissemination of guidelines alone.”
Quote in the paperSubstantial claim - Also stated in: § Authors' conclusions · hedged
- Findingown data
Eight of the trials in the meta-regression included a control group that received a non-tailored intervention.
“Eight of the trials in the meta‐regression included a control group that received a non‐tailored intervention”
Quote in the paperSubstantial claim - Findingreasoning
The process of selecting strategies to address determinants was not described in detail in the included studies.
“This process was not, however, described in detail in the included studies”
Quote in the paperSubstantial claim - Findingnone given§ Agreements and disagreements with other studies and reviews
The only reviews that have directly investigated the effects of tailored interventions are the previous versions of this review.
“The only reviews that have directly investigated the effects of tailored interventions are the previous versions of this review (Baker 2010; Shaw 2005).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingreasoning
It is not clear which element of the tailored strategy approach explained effectiveness.
“Furthermore, it is not clear which element of the tailored strategy approach explained effectiveness.”
Quote in the paperSubstantial claim - Findingcitation
It is uncertain whether tailored implementation is more effective than other non-tailored interventions.
“but is unable to determine whether this approach is more effective than selecting other interventions.”
- Also stated in: § Authors' conclusions · hedged
“It is uncertain whether tailored implementation is more effective than other interventions that are not tailored, such as educational outreach visits (O'Brien 2007), or audit and feedback (Ivers 2012).”
Quote in the paperSubstantial claim0 of 2 sources checked - Also stated in: § Authors' conclusions · hedged
- Premisecitation§ Background
The effects of attempts to translate research evidence into practice and improve performance remain inconsistent.
“Despite the attractiveness of this argument, however, the effects of attempts to translate research evidence into practice and improve performance remain inconsistent (Grimshaw 2004; Grimshaw 2012; McGlynn 2003).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation§ Background
The extent to which recommendations for clinical practice based on good quality research evidence are implemented varies.
“The extent to which recommendations for clinical practice based on good quality research evidence are implemented varies.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Grol 2005
Not checked in the free run.
- cites Oxman 1995
Not checked in the free run.
- Premisecitation§ Background
A new checklist of determinants has been devised following a detailed review of studies of determinants, including recent studies.
“Following a detailed review of studies of determinants, including recent studies, a new checklist of determinants has been devised (Flottorp 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Flottorp 2013 source
Not checked in the free run.
- Premisecitation§ Background
The problem of gaps in clinical practice persists despite many research studies, including trials of interventions to implement recommended practice.
“Although the subject of many research studies in recent years, including trials of interventions to implement recommended practice, the problem persists”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisenone given§ Abstract
Change may be more likely if implementation strategies are specifically chosen to address identified determinants of practice.
“Change may be more likely if implementation strategies are specifically chosen to address these determinants.”
Quote in the paperSubstantial claim - Premisecitation§ Background
Gaps between what is recommended and what health professionals do and patients receive are common.
“Gaps between what is recommended and what health professionals do and patients receive are common”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Grol 2005
Not checked in the free run.
- cites Oxman 1995
Not checked in the free run.
- Premisecitation§ Methods
In the previous review, the presence of administrative constraints was not predictive of effectiveness.
“In the previous review, we also investigated the effect of the presence of administrative constraints (EPOC 2002), since these might limit the ability of health professionals to change their behaviour, but this variable was also not predictive of effectiveness.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites EPOC 2002
Not checked in the free run.
- Premiseown data§ Methods
In the previous review, the level of tailoring did not predict the effectiveness of tailored interventions.
“In the previous review, we addressed the level of tailoring (whether to the determinants at the level of individual health professionals, or determinants at the level of the healthcare team, or at the level of the organisation), but this did not predict the effectiveness of tailored interventions.”
Quote in the paperSubstantial claim - Interpretationnone given§ Discussion
The best estimate of the effectiveness of tailored interventions is most likely to be that of the overall analysis that included all 15 studies.
“The best estimate of the effectiveness of tailored interventions is most likely to be that of the overall analysis that included all 15 studies.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Assessment of reporting biases
Time-lag bias is unlikely to be a major problem because the included studies spanned a number of years and were not all recent publications.
“Furthermore, as the studies included in the review spanned a number of years and were not all recent publications, time‐lag bias is unlikely to be a major problem.”
Quote in the paperNot a substantial claim - Interpretationown data§ Discussion
The number of research studies into the effectiveness and mechanisms of tailored implementation is increasing.
“With 23 studies included from the previous version of the review, the finding of nine further studies suggests that the number of research studies into the effectiveness and mechanisms of tailored implementation is increasing.”
Quote in the paperNot a substantial claim - Premisecitation§ Methods
In the previous review, the rigour of the determinants analyses failed to predict effectiveness.
“However, it was difficult to judge the rigour of the analysis of determinants since little is yet known of the most useful approaches (Huntink 2014; Wensing 2014), and this variable failed to predict effectiveness.”
Quote in the paperSubstantial claim0 of 2 sources checked - Study design and conductown data§ Potential biases in the review process
The small number of studies limited the power to detect study attributes that could explain variation in intervention effectiveness.
“The small number of studies, however, limited the power to detect study attributes that could explain the variation in intervention effectiveness.”
Quote in the paperSubstantial claim - Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The overall risk of bias for Figueiras 2006 was low (3 criteria unclear risk).
“Risk of bias overall Low risk 3 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Figueiras 2006 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The overall risk of bias for Coenen 2004 was unclear (6 unclear risk, 1 high risk).
“Risk of bias overall Unclear risk 6 unclear risk, 1 high risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coenen 2004 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The overall risk of bias for Fairall 2012 was low (3 criteria unclear risk).
“Risk of bias overall Low risk 3 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fairall 2012 source
Not checked in the free run.
- Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The overall risk of bias for Evans 1997 was high (3 high risk criteria, 2 unclear risk).
“Risk of bias overall High risk 3 high risk criteria, 2 unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Evans 1997 source
Not checked in the free run.
- Interpretationreasoning§ Discussion
The completeness and applicability of the evidence are limited by the current level of development of the methods of tailoring.
“The completeness and applicability of the evidence are limited by the current level of development of the methods of tailoring.”
Quote in the paperSubstantial claim - Study design and conductnone given§ Potential biases in the review process
The review was limited to randomised controlled trials.
“The review was limited to randomised controlled trials (RCTs)”
Quote in the paperSubstantial claim - Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
For interventions tailored to address identified determinants of practice compared to non-tailored interventions, the certainty of evidence for implementation of recommended practice is moderate (3) for randomised trials.
“4 Randomised trials (4) Serious risk of bias (‐0.5) Important inconsistency (‐0.5) No serious indirectness No serious imprecision None Moderate (3)”
Quote in the paperSubstantial claim - Interpretationreasoning§ Certainty of the evidence
The amount of evidence has improved.
“Therefore, the amount of evidence has improved.”
Quote in the paperNot a substantial claim - Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
For interventions tailored to address identified determinants of practice compared to non-tailored interventions, the certainty of evidence for implementation of recommended practice is moderate (3) for cluster-RCTs.
“Outcome: Implementation of recommended practice, e.g. clinical practice guideline recommendations 15 (8 studies included in meta‐regression) Cluster‐RCTs (4) Borderline risk of bias (‐0.5) Important inconsistency (‐0.5) No indirectness No imprecision None 3”
Quote in the paperSubstantial claim - Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
For interventions tailored to address identified determinants of practice compared to no intervention, the certainty of evidence for implementation of recommended practice is moderate (3) for randomised trials.
“4 Randomised trials (4) Serious risk of bias (‐0.5) Important inconsistency (‐0.5) No serious indirectness No serious imprecision None Moderate (3)”
Quote in the paperSubstantial claim - Study design and conductcitation§ Potential biases in the review process
Electronic handsearching risks overlooking otherwise unpublished studies reported in non-indexed conference abstracts and journal supplements.
“A potential limitation of electronic handsearching is that this approach, in contrast to handsearching print journals, risks overlooking otherwise unpublished studies reported in (non‐indexed) conference abstracts and journal supplements (Hopewell 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hopewell 2002 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The overall risk of bias for Beeckman 2013 was unclear (2 unclear risk, 1 high risk criteria).
“Risk of bias overall Unclear risk 2 unclear risk, 1 high risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Beeckman 2013 source
Not checked in the free run.
- Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The overall risk of bias for Cheater 2006 was low (2 criteria unclear risk).
“Risk of bias overall Low risk 2 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Cheater 2006 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The overall risk of bias for Fretheim 2006 was low (1 criterion unclear risk).
“Risk of bias overall Low risk 1 criterion unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fretheim 2006 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Karuza 1995, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Similar baseline outcomes”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
The overall risk of bias for Goodwin 2001 was unclear (1 high risk, 4 unclear risk criteria).
“Risk of bias overall Unclear risk 1 high risk, 4 unclear risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Goodwin 2001 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Langham 2002, blinding of outcome assessment was at high risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes High risk Participating practices collected the data themselves”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langham 2002
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Karuza 1995, overall risk of bias was high.
“Risk of bias overall High risk 4 unclear risk criteria, including randomisation sequence and allocation concealment”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Matchar 2002, incomplete outcome data was at high risk of bias.
“Incomplete outcome data (attrition bias) All outcomes High risk 30% attrition is reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Matchar 2002, overall risk of bias was high.
“Risk of bias overall High risk 5 unclear risk criteria, including allocation concealment”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Santoso 1996, overall risk of bias was high.
“Risk of bias overall High risk 6 unclear risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Santoso 1996 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Scott 2013, overall risk of bias was low.
“Risk of bias overall Low risk 1 criterion unclear risk.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott 2013 source
Not checked in the free run.
- Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Soumerai 1998, contamination was at low risk of bias.
“Contamination Low risk Hospitals were randomised, large cities being randomised as clusters to avoid contamination”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Soumerai 1998, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk No hospitals were reported as withdrawing”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Simon 2005, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk Each time period had a different cohort of patients”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
- Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In Simon 2005, blinding of outcome assessment was at unclear risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk The method of collecting prescribing data is not clear, but was probably from an electronic medical record”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
- Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255
In the Dutch cluster-RCT, the risk of contamination bias was judged low because randomisation was at hospital and nursing home level.
“Contamination Low risk Randomised at hospital and nursing home level”
Quote in the paperNot a substantial claim
- Classified as probably not a substantial claim. 187
- May combine two claims. 29
- The quote only partly states this claim. 2
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ ResultsSeven included studies are ongoing and seven are awaiting assessment.
“Seven are ongoing studies (Ongoing studies) and seven are awaiting assessment (Studies awaiting classification).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsThe remaining 17 studies were not eligible for meta-regression because they either did not assess a suitable binary outcome or reported no data at baseline.
“The remaining 17 studies were not eligible for meta‐regression because they either did not assess a suitable binary outcome, or they reported no data at baseline.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingcitation§ DiscussionIn this update, we identified an additional nine studies, seven of which had been published since the previous version of the review.
“In this update of our review of randomised trials of tailored implementation interventions, we identified an additional nine studies, seven of which had been published since the previous version of the review (Baker 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Baker 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ ResultsTwenty-three of the included studies had been included in the previous version of the review, but three studies from that review were excluded because their interventions were not assessed as meeting the criteria for tailoring.
“Twenty‐three of the studies had been included in the previous version of the review, but we excluded three studies from that review because the interventions were not assessed on this occasion as meeting the criteria for tailoring (Davies 2002; Sehgal 2002; Verhoeven 2005).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Findingown data§ ResultsNone of the assessed study attributes (risk of bias, explicit use of theory, adjustment to local factors, number of domains addressed) were found to be associated with the reported effectiveness of tailored interventions.
“Separate models were fitted dependent on the intervention delivered to the control group (none or non‐tailored), but none were found to be associated with the reported effectiveness of the tailored interventions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsWe included 15 of 32 studies in the meta-regression analysis.
“We included 15 of 32 studies in the meta‐regression analysis (Table 2; Table 3).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Findingnone given§ AbstractWe added nine studies to this review to bring the total number of included studies to 32 comparing an intervention tailored to address identified determinants of practice to no intervention or an intervention(s) not tailored to the determinants.
“We added nine studies to this review to bring the total number of included studies to 32 comparing an intervention tailored to address identified determinants of practice to no intervention or an intervention(s) not tailored to the determinants.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ ResultsWe screened 9403 unique citations and reviewed the full text of 360.
“We screened 9403 unique citations (Figure 1) and reviewed the full text of 360.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone given§ DiscussionOur overall finding is similar to that of the previous review.
“Despite the increase in the number of studies, however, our overall finding is similar to that of the previous review.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone given§ ResultsClear reports of unintended effects of implementation interventions were not included in the studies.
“Clear reports of such effects were not included in the studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ ResultsWe excluded 106 studies with reasons and 208 with quick reference to the full text.
“We excluded 106 with reasons provided in the Characteristics of excluded studies table and we excluded 208 with quick reference to the full text.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ AbstractThe 17 studies not included in the meta-analysis had findings showing variable effectiveness consistent with the findings of the meta-regression, varying from no effect to moderate effect between studies and between outcomes within studies.
“The 17 studies not included in the meta‐analysis had findings showing variable effectiveness consistent with the findings of the meta‐regression.”
- Also stated in: § Summary of findings · plain
“The effect of tailored interventions in these studies varied from no effect to moderate effect between studies and between outcomes within studies, a finding consistent with the meta‐regression”
Quote in the paperNot a substantial claim- Also stated in: § Summary of findings · plain
May combine two claims.
Findingnone given§ Authors' conclusionsCurrently available studies have used different methods to identify determinants of practice and different approaches to selecting interventions to address the determinants.
“Currently available studies have used different methods to identify determinants of practice and different approaches to selecting interventions to address the determinants.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ MethodsWhere data were collected on the same group of patients throughout the trial (three studies), no problem with drop-outs was reported.
“Where data were collected on the same group of patients throughout the trial (three studies), no problem with drop‐outs was reported.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown data§ ResultsIn sensitivity analyses using higher ICC estimates, the pooled odds ratio for all 15 studies was 1.54 (95% CI 1.27 to 1.86, P < 0.001).
“For the main analysis with all 15 studies, the pooled odds ratio was 1.54 (95% CI 1.27 to 1.86, P value < 0.001).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingreasoning§ MethodsThe majority of trials included in this review collected data before and after interventions on different patients, therefore drop-out at the patient level was not an issue for these trials.
“The majority of trials included in this review collected data before and after interventions on different patients, therefore drop‐out at the patient level was not an issue for these trials.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Findingnone given§ Authors' conclusionsIt is not possible to determine from the studies reviewed which methods of identifying determinants and tailoring interventions to account for them should be selected.
“Also, it is not possible to determine from the studies reviewed which methods of identifying determinants and tailoring interventions to account for them should be selected.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingcitation§ Certainty of the evidenceThe previous version of the review included 26 trials.
“26 were included in the previous version (Baker 2010)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Baker 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In some studies, adjustments were made at the level of the cluster (clinical team, hospital).
“Whether adjustment was made for local factors New In some studies, adjustments were made at the level of the cluster (clinical team, hospital), and these adjustments could potentially improve the intervention effect Add”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ Certainty of the evidenceThree studies included in the previous version were excluded from this update because they were assessed as no longer meeting criteria for tailoring.
“We excluded three studies from this update that had been included in the previous version of the review because we assessed them as no longer meeting our criteria for tailoring.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe studies employed various interventions to improve professional practice.
“The studies employed various interventions to improve professional practice”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255There were insufficient data in the included studies to assess healthcare outcomes, costs, and adverse events.
“Outcome: Healthcare outcomes Cluster‐RCTs Insufficient data in the included studies Outcome: Costs Cluster‐RCTs Insufficient data in the included studies Outcome: Adverse events Cluster‐RCTs Insufficient data in the included studies”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone given§ DiscussionIn the included studies, tailoring was undertaken in different ways and agreement on which methods should be used appeared to be absent.
“In the included studies, tailoring was undertaken in different ways and agreement on which methods should be used appeared to be absent.”
Quote in the paperSubstantial claimMay combine two claims.
Findingreasoning§ Agreements and disagreements with other studies and reviewsThe methods of tailoring are not yet well developed and are not described in detail in published studies.
“the methods of tailoring are not yet well developed and are not described in detail in published studies.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone given§ Certainty of the evidenceIt was possible to include 32 trials in this update.
“It was possible to include 32 trials in this update”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ What's newNine new studies were identified and added in this update.
“New searches performed to December 2014 and nine new studies identified”
- Also stated in: § What's new · plain
“We excluded three studies from the previous version of the review and added nine studies in this update, giving 32 studies in total.”
Quote in the paperNot a substantial claim- Also stated in: § What's new · plain
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone given§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255The new search for studies and content updated did not change the conclusions.
“New search for studies and content updated (no change to conclusions)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone given§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In this update, three studies were excluded from the previous version of the review and nine studies were added, giving 32 studies in total.
“We excluded three studies from the previous version of the review in this update, and added nine studies, giving 32 studies in total.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ BackgroundReviews in specific clinical fields discussed the possibility that tailored strategies might be more effective than strategies selected without taking account of determinants, but did not address the effect or costs of tailored interventions specifically.
“Although there are a number of reviews in specific clinical fields (Chaillet 2006; Kroenke 2000), which have discussed the possibility that tailored strategies might be more effective than strategies selected without taking account of determinants, these reviews did not address the effect or costs of tailored interventions specifically.”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim.
Premisenone given§ BackgroundEarlier versions of this review concluded that tailored interventions were more likely to improve professional practice than no intervention or dissemination of guidelines or educational materials alone.
“which concluded that tailored interventions were more likely to improve professional practice than no intervention or dissemination of guidelines or educational materials alone.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Premisereasoning§ AbstractDeterminants of practice can impede attempts to change health professional behaviour and are believed to influence the success of improvement strategies.
“Attempts to change the behaviour of health professionals may be impeded by a variety of different barriers, obstacles, or factors (which we collectively refer to as determinants of practice).”
- Also stated in: § Background · hedged
“determinants are believed to influence the success of improvement strategies.”
Quote in the paperSubstantial claim- Also stated in: § Background · hedged
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ BackgroundThere can be delays before the findings of research are widely adopted.
“there can be delays before the findings of research are widely adopted”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Grol 2005
Not checked in the free run.
- cites Oxman 1995
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationreasoning§ BackgroundIf determinants of practice are identified and strategies are implemented that have been chosen to address them, it is reasonable to expect performance to improve.
“it would appear reasonable to expect performance to improve”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ DiscussionThe unexpected finding of a smaller effect compared with no intervention may be due to imprecision, chance, the small number of studies, and other unexplained factors.
“This unexpected finding may be due to imprecision, chance, the small number of studies, and other unexplained factors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ MethodsTwo review authors independently classified the intensity of the methods used to identify determinants.
“Two review authors independently classified the intensity of the methods used to identify determinants using the following three categories”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationreasoning§ Authors' conclusionsIt is not yet clear how best to tailor interventions and therefore not clear what the effect of an optimally tailored intervention would be; there is insufficient evidence on the most effective approaches to tailoring, including identification of determinants, prioritisation, and selection of interventions.
“It is not yet clear how best to tailor interventions and therefore not clear what the effect of an optimally tailored intervention would be.”
- Also stated in: § Plain language summary · plain
“There is insufficient evidence on the most effective approaches to tailoring, including how determinants should be identified, how decisions should be made on which determinants are most important to address, and how interventions should be selected to account for the important determinants.”
Quote in the paperSubstantial claim- Also stated in: § Plain language summary · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Assessment of reporting biasesMeta-regression was used in the analyses to account for differences between control and intervention groups at study baselines.
“In our analyses, we used meta‐regression in order to be able to account for differences between control and intervention groups at study baselines.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Assessment of reporting biasesNo language restrictions were applied in the searches or inclusion of studies.
“We applied no language restrictions in the searches or inclusion of studies.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Assessment of reporting biasesA sensitive search of major biomedical databases and trial registries was conducted.
“We conducted a sensitive search of major biomedical databases and trial registries (see Search methods for identification of studies).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ MethodsTwo review authors independently extracted the data from included studies.
“Two review authors independently extracted the data from included studies by using a revised version of the data extraction form used in the previous version of the review (Baker 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Baker 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ MethodsTwo review authors assessed the risk of bias of the included studies using the Cochrane Handbook approach.
“Two review authors assessed the risk of bias of the included studies using the approach set out in Chapter 8 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Higgins 2011
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationreasoning§ ResultsAdverse effects of implementation interventions may have been unlikely, although unintended effects are possible.
“Since the studies were of interventions designed to implement appropriate clinical practice, adverse effects may have been unlikely, although it is possible that the implementation interventions could have unintended effects.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ MethodsTwo review authors independently assessed studies for inclusion.
“Two review authors independently assessed studies for inclusion.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductcitation§ Data synthesisFor the 15 studies included in the meta-regression, estimated odds ratios for each study (adjusted for clustering) were combined using meta-regression techniques, with baseline odds ratios included as a covariate to adjust for baseline differences between intervention and control groups.
“For the 15 studies included in the meta‐regression, we combined the estimated odds ratios for each study (adjusted for clustering) using meta‐regression techniques, whereby the baseline odds ratios were included as a covariate to adjust for any baseline differences between the intervention and control groups (Sutton 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sutton 2000
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ MethodsTwo independent review authors classified the extent to which the tailored intervention was adjusted to account for local factors.
“Two independent review authors classified the extent to which the tailored intervention was adjusted to account for local factors using the following two categories”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ BackgroundBosch and colleagues undertook a qualitative analysis of 20 quality improvement studies reporting investigation of determinants.
“Bosch and colleagues undertook a qualitative analysis of 20 quality improvement studies reporting investigation of determinants (Bosch 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bosch 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ MethodsHeterogeneity for all meta-regression models was assessed using the I2 residual statistic, which represents the proportion of residual between-study variation due to heterogeneity rather than sampling variability.
“We assessed heterogeneity for all meta‐regression models using the I² residual statistic (Higgins 2003), which represents the proportion of residual between‐study variation due to heterogeneity, as opposed to sampling variability.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Higgins 2003 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisereasoning§ Assessment of reporting biasesThere is no equivalent of forest or funnel plots for meta-regression analyses, and reliance on only follow-up results to produce such plots would have provided misleading information.
“There is no equivalent of forest or funnel plots for meta‐regression analyses and reliance on only follow‐up results to produce such plots would have provided misleading information.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ BackgroundIn many studies, the reasons for believing a particular strategy would address a particular determinant were not explained.
“but in many studies the reasons for believing a particular strategy would address a particular determinant were not explained.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bosch 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Sensitivity analysisSensitivity analyses in the meta-regression assumed a larger clustering effect than in the standard analyses by using higher ICC estimates taken from Campbell.
“In the meta‐regression analyses, we carried out sensitivity analyses assuming a larger clustering effect than had been accounted for in the standard analyses, by using higher ICC estimates (i.e. the reported upper quartile range values) taken from Campbell (Campbell 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Campbell 2005 source
Not checked in the free run.
May combine two claims.
Premisecitation§ MethodsCampbell et al extracted 220 ICCs from 21 data sets and reported the results separately for both primary and secondary care settings.
“Campbell et al extracted 220 ICCs from 21 data sets and reported the results separately for both primary and secondary care settings.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Campbell 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
Interpretationreasoning§ BackgroundThere may be additional evidence on the effectiveness of tailoring or on how it can be undertaken most effectively.
“Consequently, there may be additional evidence on the effectiveness of tailoring or on how it can be undertaken most effectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown data§ Authors' conclusionsTailored implementation can be effective, but the effect is variable and tends to be small to moderate.
“Tailored implementation can be effective, but the effect is variable and tends to be small to moderate.”
- Also stated in: § Plain language summary · plain
“The findings continue to indicate that tailored interventions can change professional practice, although they are not always effective and, when they are, the effect is small to moderate.”
- Also stated in: § Discussion · plain
“Tailored implementation can be effective, but the effect is variable and tends to be small to moderate.”
Quote in the paperSubstantial claim- Also stated in: § Plain language summary · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStrategies to address determinants may be selected in different ways.
“Once determinants have been identified and those to be addressed have been chosen, strategies to address them have to be selected, but this process may be undertaken in different ways (Wensing 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wensing 2014 source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningIt is possible that use of interventions such as audit with feedback or educational outreach would have improved professional practice whether or not tailoring had been undertaken.
“it is possible that use of such interventions (for example, audit with feedback, educational outreach) would have improved professional practice whether or not tailoring had been undertaken.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIf several methods are used together, a large number of determinants may be identified.
“if several methods are used together, a large number of determinants may be identified (Krause 2014a)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Krause 2014a
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255Avorn 1992 had an unclear overall risk of bias.
“Risk of bias overall Unclear risk 5 criteria unclear risk”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255For interventions tailored to address identified determinants of practice compared to no intervention, the certainty of evidence for implementation of recommended practice is moderate (3) for cluster-RCTs.
“Outcome: Implementation of recommended practice, e.g. clinical practice guideline recommendations 17 (7 studies included in meta‐regression) Cluster‐RCTs (4) Borderline risk of bias (‐0.5) Inconsistency between studies, and between outcomes within studies (‐0.5) No serious indirectness No serious imprecision None 3”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductreasoning§ Potential biases in the review processUsing a complex search, including a sensitive RCT filter, in key electronic databases should have identified the majority of relevant, published trials.
“Using a complex search, including a sensitive RCT filter, in the key electronic databases should have identified the majority of relevant, published trials.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255The overall risk of bias for Foy 2004 was unclear (4 criteria unclear risk, including randomisation and allocation concealment).
“Risk of bias overall Unclear risk 4 criteria unclear risk, including randomisation and allocation concealment”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Foy 2004 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255Avorn 1983 had an unclear overall risk of bias.
“Risk of bias overall Unclear risk 5 criteria unclear risk”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255Adjustments at the level of the cluster could potentially improve the intervention effect.
“Whether adjustment was made for local factors New In some studies, adjustments were made at the level of the cluster (clinical team, hospital), and these adjustments could potentially improve the intervention effect Add”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDeterminants may be classified in different ways.
“Determinants may be classified in different ways (Légaré 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Légaré 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone given§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255Theories of human behaviour potentially help explain why a determinant affects practice and indicate which interventions are most likely to address the determinants.
“Use of a theory when developing an intervention In analysis Theories of human behaviour potentially help explain why a determinant affects practice and indicate which interventions are most likely to address the determinants Keep”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown data§ Potential biases in the review processThe meta-regression pooled a relatively wide variety of outcomes, but in all studies the outcomes related to processes of care and addressed the same question about effectiveness of tailored interventions.
“We pooled a relatively wide variety of outcomes in the meta‐regression analysis, although in all studies the study outcomes related to processes of care, and the studies all addressed the same question about the effectiveness of tailored interventions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe economic costs of tailoring may be higher than several other interventions because identification of determinants and tailoring involve additional steps.
“Since the identification of determinants and tailoring of strategies involve additional steps beyond the application of a particular strategy, such as education alone, the economic costs of tailoring may be higher than several other interventions.”
Quote in the paperNot a substantial claim- Rests on an assumption: The identification of determinants and tailoring of strategies involve additional steps beyond the application of a particular strategy.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255The overall risk of bias for Flottorp 2002 was unclear.
“Risk of bias overall Unclear risk Allocation concealment”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Flottorp 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255The overall risk of bias for Callahan 1994 was unclear (5 criteria unclear risk).
“Risk of bias overall Unclear risk 5 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Callahan 1994 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255The overall risk of bias for Engers 2005 was unclear (4 criteria unclear risk).
“Risk of bias overall Unclear risk 4 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Engers 2005 source
Not checked in the free run.
May combine two claims.
Interpretationreasoning§ Potential biases in the review processThis risk is more likely to be a source of bias for reviews that include interrupted time series and controlled before-after studies, because randomised trials are more likely to be identified through electronic database searches.
“However, this is more likely to be a source of bias for reviews in which interrupted time series and controlled before‐after studies are included, since in comparison with these types of studies, randomised trials are more likely to be identified through electronic database searches.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningThe economic costs of tailoring may be lower than other interventions by enabling more expensive elements to be reserved for situations when they are likely to be effective.
“Conversely, they may be lower through enabling the more expensive elements of interventions to be reserved for situations when they are likely to be effective.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoning§ Potential biases in the review processIn the meta-regression analysis, the outcomes included were either those reported as the primary outcome or, when this was not possible, the most clinically relevant measure, and therefore the introduction of bias is unlikely.
“In the meta‐regression analysis, the outcomes included were either those reported as the primary outcome or, when this was not possible, we selected the most clinically relevant measure and therefore the introduction of bias is unlikely.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDeterminants may be investigated by various methods.
“Determinants may be investigated by various methods”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Krause 2014a
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, contamination was at low risk of bias.
“Contamination Low risk Randomisation at nursing home level”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, allocation concealment was at unclear risk of bias.
“Allocation concealment (selection bias) Unclear risk Information not provided”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk 2 intervention nursing homes withdrew during the study, and 1 control home was excluded as no influenza vaccination was offered during the study period”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Leviton 1999, blinding of outcome assessment was at unclear risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk Data collection done by medical abstractors but it is not clear if they were blinded”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leviton 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Langham 2002, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk Follow‐up of 85% of patients achieved”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langham 2002
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Lakshminarayan 2010, random sequence generation was at unclear risk of bias.
“Random sequence generation (selection bias) Unclear risk A randomised block design was used, but the method for generating the randomisation sequence was not described”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lakshminarayan 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Leviton 1999, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 1 high risk and 5 unclear risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leviton 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, blinding of outcome assessment was at low risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Low risk The vaccinating professional recorded the vaccination on a website”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Karuza 1995, random sequence generation was at unclear risk of bias.
“Random sequence generation (selection bias) Unclear risk Details not reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Langham 2002, contamination was at unclear risk of bias.
“Contamination Unclear risk Practices were randomised”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langham 2002
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Langham 2002, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langham 2002
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Lakshminarayan 2010, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lakshminarayan 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Lakshminarayan 2010, baseline outcomes were at unclear risk of bias.
“Baseline outcomes Unclear risk The baseline outcomes were similar, except for onset to drug treatment within 180 minutes; not clear if this was adjusted for”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lakshminarayan 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Langham 2002, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langham 2002
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Lakshminarayan 2010, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk No loss to follow‐up after randomisation”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lakshminarayan 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Karuza 1995, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Leviton 1999, allocation concealment was at high risk of bias.
“Allocation concealment (selection bias) High risk Allocation was not undertaken independently”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leviton 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Karuza 1995, incomplete outcome data was at unclear risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Unclear risk It is not clear why the mean number of charts reviewed is lower than the 45 planned for; some charts were not available at post intervention data collection”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk Baseline characteristics comparable”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Lakshminarayan 2010, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 4 unclear risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lakshminarayan 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Karuza 1995, blinding of outcome assessment was at unclear risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk Data were collected from patient charts and it is not clear whether the data collectors were blinded”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Karuza 1995, allocation concealment was at unclear risk of bias.
“Allocation concealment (selection bias) Unclear risk Details not clear.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Leviton 1999, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leviton 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Langham 2002, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 1 high risk, 5 unclear risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langham 2002
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Leviton 1999, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk Only 1 hospital withdrew after randomisation”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leviton 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Lakshminarayan 2010, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk Patient characteristics were similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lakshminarayan 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Langham 2002, baseline characteristics were at unclear risk of bias.
“Baseline characteristics Unclear risk Baseline patient characteristics comparable other than age, BP, and smoking prevalence in 1 group, but not clear whether adjusted for”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langham 2002
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Leviton 1999, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes were similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leviton 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Lakshminarayan 2010, contamination was at low risk of bias.
“Contamination Low risk Hospitals randomised”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lakshminarayan 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Lakshminarayan 2010, other bias was at low risk of bias.
“Other bias Low risk Low likelihood of contamination; baseline characteristics of patients similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lakshminarayan 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Leviton 1999, contamination was at low risk of bias.
“Contamination Low risk The hospital was the unit of randomisation”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leviton 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Karuza 1995, contamination was at low risk of bias.
“Contamination Low risk Practice groups randomised”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Langham 2002, other bias was at unclear risk of bias.
“Other bias Unclear risk Baseline patients' characteristics broadly similar; practices were in a single locality and contamination may have been possible”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langham 2002
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Karuza 1995, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk No patient differences between study groups”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Karuza 1995 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Murphy 2009, blinding of outcome assessment was at unclear risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk Data were collected from patient records by a research nurse”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murphy 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Ross‐Degnan 1996, contamination was at low risk of bias.
“Contamination Low risk Pharmacies stratified by geographical location prior to randomisation”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross‐Degnan 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Murphy 2009, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes comparable”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murphy 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Ross‐Degnan 1996, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk Data were collected from all pharmacies in the study”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross‐Degnan 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Santoso 1996, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Santoso 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Ross‐Degnan 1996, other bias was at unclear risk of bias.
“Other bias Unclear risk There are no baseline performance data; the risk of contamination is unclear”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross‐Degnan 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk Characteristics of hospitals and professionals similar at baseline, although there was an uneven distribution of patients with heart failure, but there was adjustment”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Ross‐Degnan 1996, allocation concealment was at unclear risk of bias.
“Allocation concealment (selection bias) Unclear risk Unable to assess”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross‐Degnan 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Matchar 2002, other bias was at unclear risk of bias.
“Other bias Unclear risk Contamination may have been possible, since geographically related practices were randomised to intervention and control groups. Patient characteristics were similar in both groups”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Matchar 2002, contamination was at low risk of bias.
“Contamination Low risk Groups of geographically related practices were randomised”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 2 unclear risk criteria (1 allocation concealment)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Santoso 1996, baseline characteristics were at unclear risk of bias.
“Baseline characteristics Unclear risk Baseline characteristics not reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Santoso 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Ross‐Degnan 1996, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross‐Degnan 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Looijmans 2010, other bias was at low risk of bias.
“Other bias Low risk Comparable baseline characteristics in the study groups; contamination unlikely”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Looijmans 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Matchar 2002, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, random sequence generation was at unclear risk of bias.
“Random sequence generation (selection bias) Unclear risk Coin toss was used to assign hospitals to intervention or control groups”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Santoso 1996, contamination was at low risk of bias.
“Contamination Low risk Randomisation at the level of the district”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Santoso 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Murphy 2009, contamination was at low risk of bias.
“Contamination Low risk Randomisation at general practice level”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murphy 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Matchar 2002, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk No differences at baseline”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Ross‐Degnan 1996, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 4 unclear risk, 1 high risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross‐Degnan 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Murphy 2009, other bias was at low risk of bias.
“Other bias Low risk Baseline characteristics similar; low likelihood of contamination”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murphy 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Santoso 1996, other bias was at unclear risk of bias.
“Other bias Unclear risk Contamination is unlikely; baseline characteristics of the health centres are not reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Santoso 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Santoso 1996, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Santoso 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Matchar 2002, allocation concealment was at unclear risk of bias.
“Allocation concealment (selection bias) Unclear risk Process not reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Murphy 2009, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murphy 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk There were baseline differences in some outcomes, but adjusted for”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Murphy 2009, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk Intervention and control groups comparable”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murphy 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Santoso 1996, allocation concealment was at unclear risk of bias.
“Allocation concealment (selection bias) Unclear risk Details not provided”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Santoso 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Ross‐Degnan 1996, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross‐Degnan 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Matchar 2002, random sequence generation was at low risk of bias.
“Random sequence generation (selection bias) Low risk A computer random number function was used”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Matchar 2002, baseline characteristics were at unclear risk of bias.
“Baseline characteristics Unclear risk There were no differences in patient characteristics between study groups. No data on clinicians”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Matchar 2002, blinding of outcome assessment was at unclear risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk Whether or not the data abstractors were blinded is not reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Matchar 2002 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Murphy 2009, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 3 unclear risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Murphy 2009 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Ross‐Degnan 1996, baseline characteristics were at unclear risk of bias.
“Baseline characteristics Unclear risk Baseline characteristics not reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross‐Degnan 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Santoso 1996, blinding of participants and personnel was at unclear risk of bias.
“Blinding of participants and personnel (performance bias) All outcomes Unclear risk It would not have been possible to blind staff of the study health centres to the intervention group”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Santoso 1996 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, allocation concealment was at low risk of bias.
“Allocation concealment (selection bias) Low risk Allocation was undertaken by an independent researcher”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Scott 2013, other bias was at low risk of bias.
“Other bias Low risk Low risk of contamination”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Simon 2005, other bias was at unclear risk of bias.
“Other bias Unclear risk The study took place in a single health maintenance organisation and contamination may be a risk. Baseline adherence was higher than national figures”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, blinding of outcome assessment was at unclear risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk It is not clear whether the data collectors were blind to study groups”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk No practices withdrew”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Simon 2005, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk More physicians in the control group were male. Otherwise, patient and physician characteristics were similar between groups (adjusted for)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, other bias was at low risk of bias.
“Other bias Low risk Contamination unlikely; baseline characteristics similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Scott 2013, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk Intention‐to‐treat analysis; all included hospitals completed the study”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk Patient characteristics comparable except for education and macrovascular complications (adjusted for)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Simon 2005, random sequence generation was at unclear risk of bias.
“Random sequence generation (selection bias) Unclear risk No details given”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Scott 2013, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Soumerai 1998, other bias was at low risk of bias.
“Other bias Low risk Baseline patient characteristics were similar. Contamination unlikely”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, contamination was at low risk of bias.
“Contamination Low risk Randomisation at the hospital level”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Simon 2005, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 4 unclear risk criteria”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Simon 2005, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Soumerai 1998, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, random sequence generation was at unclear risk of bias.
“Random sequence generation (selection bias) Unclear risk A random number table was used”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Simon 2005, contamination was at low risk of bias.
“Contamination Low risk Practices were randomised”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Soumerai 1998, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Scott 2013, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Simon 2005, baseline outcomes were at low risk of bias.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Scott 2013, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk Characteristics similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, baseline outcomes were at unclear risk of bias.
“Baseline outcomes Unclear risk No baseline data”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Soumerai 1998, allocation concealment was at unclear risk of bias.
“Allocation concealment (selection bias) Unclear risk Method not described”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Soumerai 1998, random sequence generation was at unclear risk of bias.
“Random sequence generation (selection bias) Unclear risk Method of sequence generation not described”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Soumerai 1998, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 4 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, blinding of outcome assessment was at unclear risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk There is no information on blinding of data collection”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Scott 2013, contamination was at low risk of bias.
“Contamination Low risk Hospitals randomised”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Scott 2013, allocation concealment was at low risk of bias.
“Allocation concealment (selection bias) Low risk Allocation was undertaken by a data management centre independent of the researchers”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scott 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Soumerai 1998, blinding of outcome assessment was at unclear risk of bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk It is not clear if the data collectors were blinded”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 4 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Soumerai 1998, baseline characteristics were at low risk of bias.
“Baseline characteristics Low risk Patient characteristics were similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soumerai 1998 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Schouten 2007, incomplete outcome data was at low risk of bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk All hospitals completed the study”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schouten 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Simon 2005, allocation concealment was at unclear risk of bias.
“Allocation concealment (selection bias) Unclear risk No details given”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Simon 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of detection bias was judged low because data were based on a patient-completed questionnaire.
“Blinding of outcome assessment (detection bias) All outcomes Low risk Symptom questionnaire completed by patients”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the risk of detection bias from blinding of outcome assessment was judged unclear.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk It is not clear if data collectors were blind to study group.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the risk of bias from baseline outcomes was judged low because baseline outcomes were similar.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT in nursing homes and hospitals, the risk of selection bias from random sequence generation was judged unclear.
“Random sequence generation (selection bias) Unclear risk”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the risk of attrition bias was judged low because adequate follow-up was achieved.
“Incomplete outcome data (attrition bias) All outcomes Low risk Adequate follow‐up achieved”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the risk of selection bias from allocation concealment was judged unclear because details were not reported.
“Allocation concealment (selection bias) Unclear risk Details not reported”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, contamination was at low risk of bias.
“Contamination Low risk General practices were randomised”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of contamination bias was judged low because randomisation was at general practice level.
“Contamination Low risk Randomised at general practice level”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of bias from baseline outcomes was judged low because baseline outcomes were similar.
“Baseline outcomes Low risk Baseline outcomes similar”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, other bias was at low risk of bias.
“Other bias Low risk Baseline characteristics similar; low likelihood of contamination”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the overall risk of bias was judged unclear because 5 criteria were at unclear risk.
“Risk of bias overall Unclear risk 5 unclear risk criteria”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, selective reporting was at low risk of bias.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of bias from baseline characteristics was judged low because baseline characteristics were comparable.
“Baseline characteristics Low risk Baseline characteristics comparable”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of performance bias was judged low because data were based on a questionnaire completed by patients.
“Blinding of participants and personnel (performance bias) All outcomes Low risk Data were based on a questionnaire completed by patients”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In van Bruggen 2008, overall risk of bias was unclear.
“Risk of bias overall Unclear risk 4 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van Bruggen 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the overall risk of bias was judged unclear because 2 criteria were at unclear risk.
“Risk of bias overall Unclear risk 2 criteria unclear risk”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the risk of other bias was judged unclear because contamination across wards could have occurred.
“Other bias Unclear risk Quote:”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of selection bias from allocation concealment was judged unclear because the method of allocation was not described.
“Allocation concealment (selection bias) Unclear risk Method of allocation not described”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the risk of bias from baseline characteristics was judged low because baseline characteristics were similar.
“Baseline characteristics Low risk Baseline characteristics similar”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of attrition bias was judged low because over 84% of patients in each study group provided data.
“Incomplete outcome data (attrition bias) All outcomes Low risk Over 84% of patients in each study group provided data”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the previous review (Baker 2010), Bayesian and classical analyses produced similar results.
“In the previous review (Baker 2010), we included a Bayesian analysis as well as a classical analysis, but since these approaches produced similar results, we used only the classical analysis in this review.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Baker 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the risk of performance bias from blinding of participants and personnel was judged unclear because nurses could not be blinded to study group.
“Blinding of participants and personnel (performance bias) All outcomes Unclear risk Nurses could not be blinded to study group”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of other bias was judged low because practitioners and patients were generally similar and randomisation by practice reduced the risk of contamination.
“Other bias Low risk Generally similar practitioners and patients in study and control groups; randomised by practice, reducing the risk of contamination”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of selection bias from random sequence generation was judged low because a computer-generated list of random numbers was used.
“Random sequence generation (selection bias) Low risk Quote:”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In Zwarenstein 2007, the risk of reporting bias was judged unclear because there was no information on adherence to recommended practice.
“Selective reporting (reporting bias) Unclear risk No information on adherence to recommended practice”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zwarenstein 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255In the Dutch cluster-RCT, the risk of reporting bias was judged low because appropriate outcomes were reported.
“Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Tailored intervention strategies are frequently recommended among approaches to implementation of improvement in health professional performance.
“Tailored intervention strategies are frequently recommended among approaches to the implementation of improvement in health professional performance.”
The paper relies on this without support.
The determinants of practice may vary in different healthcare settings, groups of healthcare professionals, or clinical tasks.
“The determinants may vary in different healthcare settings, groups of healthcare professionals, or clinical tasks.”
The paper relies on this without support.
The mRCT includes randomised trial records held on the National Institutes of Health ClinicalTrials.gov website.
“As the mRCT includes randomised trial records held on the National Institutes of Health (NIH) ClinicalTrials.gov website (available at: http://clinicaltrials.gov/), we did not search the latter registry.”
The paper relies on this without support.
The identification of determinants and tailoring of strategies involve additional steps beyond the application of a particular strategy.
“Since the identification of determinants and tailoring of strategies involve additional steps beyond the application of a particular strategy, such as education alone”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Systematic reviews of interventions designed to change professional practice have shown only small numbers of rigorous evaluations reporting the use of theory to assess implementation problems or guide intervention design.
“Despite this, systematic reviews of interventions designed to change professional practice have shown only small numbers of rigorous evaluations reporting the use of theory to assess implementation problems or guide intervention design [8,13,14].”
From A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems (2017) · cites this paper as [13]
No specific method for identifying and prioritizing determinants and selecting implementation strategies has been proven superior.
“and no specific method has been proven superior (37).”
From Enhancing the Impact of Implementation Strategies in Healthcare: A Research Agenda (2019) · cites this paper as [37]
Strategies are not always well-matched to the contexts in which they are deployed, including the interventions to be implemented, settings, stakeholder preferences, and implementation determinants.
“Consequently, strategies are not always well-matched to the contexts in which they are deployed, including the interventions to be implemented, settings, stakeholder preferences, and implementation determinants (37, 42, 54).”
From Enhancing the Impact of Implementation Strategies in Healthcare: A Research Agenda (2019) · cites this paper as [37]
In the systematic review of 32 studies, the methods used to identify and prioritize determinants and select implementation strategies were not often well-described.
“however, the methods used to identify and prioritize determinants and select implementation strategies were not often well-described”
From Enhancing the Impact of Implementation Strategies in Healthcare: A Research Agenda (2019) · cites this paper as [37]
The evidence regarding the superiority of multifaceted and tailored implementation strategies to single-component strategies has been mixed.
“While the use of multifaceted and tailored implementation strategies is intuitive and has considerable face validity (29), the evidence regarding their superiority to single-component strategies has been mixed (37, 39, 40).”
From Enhancing the Impact of Implementation Strategies in Healthcare: A Research Agenda (2019) · cites this paper as [37]
A systematic review of 32 studies testing strategies tailored to address determinants concluded that tailored approaches to implementation were more effective than no strategy or a strategy not tailored to determinants.
“A systematic review of 32 studies testing strategies tailored to address determinants concluded that tailored approaches to implementation were more effective than no strategy or a strategy not tailored to determinants; however, the methods used to identify and prioritize determinants and select implementation strategies were not often well-described and no specific method has been proven superior”
From Enhancing the Impact of Implementation Strategies in Healthcare: A Research Agenda (2019) · cites this paper as [37]
Tailored implementation strategies had a pooled odds ratio of 1.56 (95% CI 1.27-1.93, p < 0.001) in a meta-regression using 15 randomized trials.
“Tailored implementation strategies (37) | 32 RCTs | Meta-regression using 15 randomized trials. Pooled odds ratio of 1.56 (95% CI, 1.27–1.93, p < 0.001)”
From Enhancing the Impact of Implementation Strategies in Healthcare: A Research Agenda (2019) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Cheater 2006 point estimate falls outside its confidence interval
MinorThe reported estimate of −2.3 is below the lower bound of its stated 95% confidence interval, −1.63.
“‐2.3”
“95% CI ‐1.63 to 1.7”
Risk-of-bias categories account for only 31 studies
MinorThe reported categories contain 4 high-risk, 21 unclear-risk, and 6 low-risk studies, totaling 31 rather than the 32 included studies.
Reported 32 · recomputed 31
“We assessed the overall risk of bias as high in four studies (Evans 1997; Hux 1999; Matchar 2002; Santoso 1996), unclear in 21”
Footnote gives 14 rather than 17 studies outside the meta-regression
MinorThe summary-of-findings text says 17 studies were not included in the meta-regression, but its footnote says 14.
“17 other studies could not be included in the meta‐regression.”
“The results of 14 studies not included in the meta‐regression indicated that, on average, tailored interventions improve professional practice.”
Sensitivity analysis changes the no-intervention subgroup from seven to eight studies
MinorThe main subgroup analysis identifies seven studies whose control group received no intervention. The sensitivity-analysis paragraph describes the corresponding subgroup as eight studies.
“the pooled odds ratio for the seven studies that received no control intervention was 1.36”
“for the eight studies where the control group received no intervention the OR was 1.30”
Callahan 1994 is high risk in the table but omitted from the high-risk count
MinorThe risk-of-bias summary names four high-risk studies, whereas the study-results table also labels Callahan 1994 high risk.
“We assessed the overall risk of bias as high in four studies (Evans 1997; Hux 1999; Matchar 2002; Santoso 1996)”
“High Callahan 1994”
Reported minimum follow-up odds ratio exceeds a table value
MinorThe text gives 1.08 as the lowest follow-up odds ratio among the 15 studies, but Table 3 reports 1.07 for Coenen 2004.
“The odds ratios at follow‐up, adjusted for clustering, ranged from 1.08 to 10.59.”
“Coenen 2004 Antibiotics not prescribed 0.80 (0.49 to 1.32) 1.07 (0.59 to 1.92)”
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
Hoffmann, T. C., Glasziou, P. P., Boutron, I., Milne, R., Perera, R., Moher, D., Altman, D. G., Barbour, V., Macdonald, H., Johnston, M., et al. (2014) · BMJ · doi:10.1136/bmj.g1687 · Cited by 10,548 · see citing works
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · see citing works
Self-citationWhy Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement
Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P.-A. C., & Rubin, H. R. (1999) · JAMA · doi:10.1001/jama.282.15.1458 · Cited by 6,677 · see citing works
Audit and feedback: effects on professional practice and healthcare outcomes
Ivers, N., Jamtvedt, G., Flottorp, S., Young, J. M., Odgaard-Jensen, J., French, S. D., O'Brien, M. A., Johansen, M., Grimshaw, J., & Oxman, A. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000259.pub3 · Cited by 5,485 · see citing works
Self-citationThe quality of health care delivered to adults in the United States
McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa022615 · Cited by 5,079 · see citing works
Cane, J., O’Connor, D., & Michie, S. (2012) · Implementation Science · doi:10.1186/1748-5908-7-37 · Cited by 4,888 · see citing works
(2008) · Cited by 3,790 · see citing works
Effectiveness and efficiency of guideline dissemination and implementation strategies
Grimshaw, J., Thomas, R., MacLennan, G., Fraser, C., Ramsay, C., Vale, L., Whitty, P., Eccles, M., Matowe, L., Shirran, L., et al. (2004) · Health Technology Assessment · doi:10.3310/hta8060 · Cited by 3,044 · see citing works
Self-citationKnowledge translation of research findings
Grimshaw, J. M., Eccles, M. P., Lavis, J. N., Hill, S. J., & Squires, J. E. (2012) · Implementation Science · doi:10.1186/1748-5908-7-50 · Cited by 2,407 · see citing works
Self-citationOxman, A. D., Thomson, M., Davis, D. A., & Haynes, R. B. (1995) · PubMed Central · Cited by 1,847 · see citing works
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795 · see citing works
Educational outreach visits: effects on professional practice and health care outcomes
O'Brien, M. A., Rogers, S., Jamtvedt, G., Oxman, A. D., Odgaard-Jensen, J., Kristoffersen, D. T., Forsetlund, L., Bainbridge, D., Freemantle, N., Davis, D., et al. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000409.pub2 · Cited by 1,279 · see citing works
Flottorp, S. A., Oxman, A. D., Krause, J., Musila, N. R., Wensing, M., Godycki-Cwirko, M., Baker, R., & Eccles, M. P. (2013) · Implementation Science · doi:10.1186/1748-5908-8-35 · Cited by 1,138 · see citing works
Self-citationBaker, R., Camosso-Stefinovic, J., Gillies, C., Shaw, E. J., Cheater, F., Flottorp, S., & Robertson, N. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005470.pub2 · Cited by 1,003 · see citing works
Self-citationUsing Programme Theory to Evaluate Complicated and Complex Aspects of Interventions
Rogers, P. J. (2008) · Evaluation · doi:10.1177/1356389007084674 · Cited by 999 · see citing works
Harbord, R. M., & Higgins, J. P. T. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800403 · Cited by 897 · see citing works
Improving Drug-Therapy Decisions through Educational Outreach
Avorn, J., & Soumerai, S. B. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082406 · Cited by 854 · see citing works
May, C., Finch, T., Mair, F., Ballini, L., Dowrick, C., Eccles, M., Gask, L., MacFarlane, A., Murray, E., Rapley, T., et al. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-148 · Cited by 768 · see citing works
Self-citationA Simple Method for the Analysis of Clustered Binary Data
Rao, J. N. K., & Scott, A. J. (1992) · Biometrics · doi:10.2307/2532311 · Cited by 696 · see citing works
Knowledge Translation in Health Care: Moving from Evidence to Practice
(2009) · International Journal of Health Care Quality Assurance · doi:10.1108/ijhcqa.2009.06222fae.002 · Cited by 689 · see citing works
Why Don't Physicians Follow Clinical Practice Guidelines? A Framework for Improvement
Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. E. H., Abboud, P.-A. C., & Rubin, H. R. (1999) · Pediatric Research · doi:10.1203/00006450-199904020-00719 · Cited by 604 · see citing works
Improving Patient Care: The Implementation of Change in Clinical Practice
Cosby, J. (2006) · BMJ Quality & Safety · doi:10.1136/qshc.2005.016824 · Cited by 560 · see citing works
An implementation research agenda
Eccles, M. P., Armstrong, D., Baker, R., Cleary, K., Davies, H., Davies, S., Glasziou, P., Ilott, I., Kinmonth, A.-L., Leng, G., et al. (2009) · Implementation Science · doi:10.1186/1748-5908-4-18 · Cited by 481 · see citing works
Self-citationSoumerai, S. B., McLaughlin, T. J., Gurwitz, J. H., Guadagnoli, E., Hauptman, P. J., Borbas, C., Morris, N., McLaughlin, B., Gao, X., Willison, D. J., et al. (1998) · JAMA · doi:10.1001/jama.279.17.1358 · Cited by 479 · see citing works
Avery, A. J., Rodgers, S., Cantrill, J. A., Armstrong, S., Cresswell, K. M., Eden, M., Elliott, R. A., Howard, R., Kendrick, D., Morris, C. J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61817-5 · Cited by 457 · see citing works
Middleton, S., McElduff, P., Ward, J., Grimshaw, J., Dale, S., D’Este, C. A., Drury, P., Griffiths, R., Cheung, N. W., Quinn, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61485-2 · Cited by 420 · see citing works
Feder, G., Davies, R. A., Baird, K., Dunne, D., Eldridge, S., Griffiths, C., Gregory, A., Howell, A., Johnson, M., Ramsay, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61179-3 · Cited by 406 · see citing works
A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes
Avorn, J., Soumerai, S. B., Everitt, D. E., Ross-Degnan, D., Beers, M. H., Sherman, D., Salem-Schatz, S. R., & Fields, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207163270306 · Cited by 397 · see citing works
Hardeman, W., Sutton, S., Griffin, S., Johnston, M., White, A., Wareham, N. J., & Kinmonth, A. L. (2005) · Health Education Research · doi:10.1093/her/cyh022 · Cited by 311 · see citing works
Ploeg, J., Davies, B., Edwards, N. C., Gifford, W., & Elliott-Miller, P. (2007) · Worldviews on Evidence-Based Nursing · doi:10.1111/j.1741-6787.2007.00106.x · Cited by 310 · see citing works
McLaughlin, T. J. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.7.799 · Cited by 308 · see citing works
Improving treatment of late life depression in primary care: a randomized clinical trial
Callahan, C. M., Hendrie, H. C., Dittus, R. S., Brater, D. C., Hui, S. L., & Tierney, W. M. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06555.x · Cited by 304 · see citing works
Fairall, L., Bachmann, M. O., Lombard, C., Timmerman, V., Uebel, K., Zwarenstein, M., Boulle, A., Georgeu, D., Colvin, C. J., Lewin, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60730-2 · Cited by 302 · see citing works
Leveille, S. G., Wagner, E. H., Davis, C., Grothaus, L. C., Wallace, J. I., Logerfo, M., & Kent, D. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb04533.x · Cited by 285 · see citing works
Campbell, M. K., Fayers, P. M., & Grimshaw, J. M. (2005) · Clinical Trials · doi:10.1191/1740774505cn071oa · Cited by 275 · see citing works
Tailoring quality improvement interventions to identified barriers: a multiple case analysis
Bosch, M., Van Der Weijden, T., Wensing, M., & Grol, R. (2007) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2006.00660.x · Cited by 272 · see citing works
Self-citationAcademic Detailing to Improve Use of Broad-Spectrum Antibiotics at an Academic Medical Center
Solomon, D. H., Houten, L. V., Glynn, R. J., Baden, L. R., Curtis, K., Schrager, H. M., & Avorn, J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.15.1897 · Cited by 270 · see citing works
Inouye, S. K. (2000) · Annals of Medicine · doi:10.3109/07853890009011770 · Cited by 242 · see citing works
Evidence-Based Strategies for Implementing Guidelines in Obstetrics: A Systematic Review
Chaillet, N., Dubé, E., Dugas, M., Audibert, F., Tourigny, C., Fraser, W. D., & Dumont, A. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000236434.74160.8b · Cited by 233 · see citing works
Psychoactive medication use in intermediate-care facility residents
Beers, M. H. (1988) · JAMA · doi:10.1001/jama.260.20.3016 · Cited by 229 · see citing works
DOWNS, M. G., Turner, S., Bryans, M., Wilcock, J., Keady, J. D., Levin, E., O’Carroll, R. E., Howie, K., & Iliffe, S. (2006) · BMJ · doi:10.1136/bmj.332.7543.692 · Cited by 213 · see citing works
Altiner, A., Brockmann, S., Sielk, M., Wilm, S., Wegscheider, K., & Abholz, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm254 · Cited by 213 · see citing works
Why do GPs not implement evidence-based guidelines? A descriptive study
Cranney, M., Warren, E., Barton, S., Gardner, K., & Walley, T. (2001) · Family Practice · doi:10.1093/fampra/18.4.359 · Cited by 212 · see citing works
Figueiras, A., Herdeiro, M. T., Polónia, J., & Gestal-Otero, J. J. (2006) · JAMA · doi:10.1001/jama.296.9.1086 · Cited by 204 · see citing works
Brinkman, W. B., Geraghty, S. R., Lanphear, B. P., Khoury, J. C., Gonzalez del Rey, J. A., DeWitt, T. G., & Britto, M. T. (2007) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.161.1.44 · Cited by 204 · see citing works
Welschen, I., Kuyvenhoven, M. M., Hoes, A. W., & Verheij, T. J. (2004) · BMJ · doi:10.1136/bmj.38182.591238.eb · Cited by 196 · see citing works
Psychoactive Medication Use in Intermediate-Care Facility Residents
Beers, M. H. (1988) · JAMA · doi:10.1001/jama.1988.03410200072028 · Cited by 190 · see citing works
A Behavioral Intervention to Improve Obstetrical Care
Althabe, F., Buekens, P. M., Bergel, E. F., Belizán, J. M., Campbell, M. K., Moss, N., Hartwell, T., & Wright, L. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa071456 · Cited by 189 · see citing works
Tailored Implementation for Chronic Diseases (TICD): a project protocol
Wensing, M., Oxman, A., Baker, R., Godycki-Cwirko, M., Flottorp, S., Szecsenyi, J., Grimshaw, J., & Eccles, M. (2011) · Implementation Science · doi:10.1186/1748-5908-6-103 · Cited by 184 · see citing works
Self-citationCheater, F., Baker, R., Gillies, C., Hearnshaw, H., Flottorp, S. A., Robertson, N., Shaw, E. J., & Oxman, A. D. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005470 · Cited by 182 · see citing works
Self-citationKrause, J., van Lieshout, J., Klomp, R., Huntink, E. M., Aakhus, E., Flottorp, S. A., Jäger, C., Steinhaeuser, J., Godycki-Ćwirko, M., Kowalczyk, A., et al. (2014) · Implementation Science · doi:10.1186/s13012-014-0102-3 · Cited by 178 · see citing works
Self-citationImplementation Barriers for General Practice Guidelines on Low Back Pain
Schers, H., Wensing, M., Huijsmans, Z., van Tulder, M. W., & Grol, R. P. T. M. (2001) · Spine · doi:10.1097/00007632-200108010-00013 · Cited by 167 · see citing works
Self-citationKroenke, K., Taylor-Vaisey, A., Dietrich, A. J., & Oxman, T. E. (2000) · Psychosomatics · doi:10.1016/s0033-3182(00)71172-8 · Cited by 164 · see citing works
Physicians??? Attitudes and Adverse Drug Reaction Reporting
Herdeiro, M. T., Figueiras, A., Polónia, J. J., & Gestal, J. J. (2005) · Drug Safety · doi:10.2165/00002018-200528090-00007 · Cited by 163 · see citing works
Improving care for minority children with asthma: professional education in public health clinics
Evans, D., Mellins, R., Lobach, K., Ramos-Bonoan, C., Pinkett-Heller, M., Wiesemann, S., Klein, I., Donahue, C., Burke, D., Levison, M., et al. (1997) · Pediatrics · doi:10.1542/peds.99.2.157 · Cited by 159 · see citing works
Flottorp, S., Oxman, A. D., Håvelsrud, K., Treweek, S., & Herrin, J. (2002) · BMJ · doi:10.1136/bmj.325.7360.367 · Cited by 154 · see citing works
Self-citationBaer, J. S., Wells, E. A., Rosengren, D. B., Hartzler, B. J., Beadnell, B. A., & Dunn, C. W. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.01.003 · Cited by 149 · see citing works
A clinical trial of tailored office systems for preventive service delivery
Goodwin, M. A., Zyzanski, S. J., Zronek, S., Ruhe, M., Weyer, S. M., Konrad, N., Esola, D., & Stange, K. C. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00310-5 · Cited by 144 · see citing works
Matchar, D. B., Samsa, G. P., Cohen, S. J., Oddone, E. Z., & Jurgelski, A. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01131-2 · Cited by 141 · see citing works
Stéphan, F., Sax, H., Wachsmuth, M., Hoffmeyer, P. J., Clergue, F., & Pittet, D. (2006) · Clinical Infectious Diseases · doi:10.1086/503837 · Cited by 136 · see citing works
Sustainability of a practice-individualized preventive service delivery intervention
Stange, K. C., Goodwin, M. A., Zyzanski, S. J., & Dietrich, A. J. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(03)00219-8 · Cited by 131 · see citing works
Leviton, L. C., Goldenberg, R. L., Baker, C. S., Schwartz, R. M., Freda, M. C., Fish, L. J., Cliver, S. P., Rouse, D. J., Chazotte, C., Merkatz, I. R., et al. (1999) · JAMA · doi:10.1001/jama.281.1.46 · Cited by 128 · see citing works
Schouten, J. A., Hulscher, M., Natsch, S., Kullberg, B. J., van der Meer, J. W. M., & Grol, R. P. T. M. (2007) · BMJ Quality & Safety · doi:10.1136/qshc.2005.017327 · Cited by 128 · see citing works
The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies
ROSS-DEGNAN, D., SOUMERAI, S. B., GOEL, P. K., BATES, J., MAKHULO, J., DONDI, N., SUTOTO, ADI, D., FERRAZ-TABOR, L., & HOGAN, R. (1996) · Health Policy and Planning · doi:10.1093/heapol/11.3.308 · Cited by 123 · see citing works
Schers, H., Braspenning, J. C. C., Drijver, R., Wensing, M., & Grol, R. P. T. M. (2000) · Europe PMC (PubMed Central) · Cited by 120 · see citing works
Self-citationBosworth, H. B., Olsen, M. K., McCant, F., Harrelson, M., Gentry, P., Rose, C., Goldstein, M. K., Hoffman, B. B., Powers, B. J., & Oddone, E. Ž. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.03.004 · Cited by 118 · see citing works
Hopewell, S., Clarke, M., Lusher, A., Lefebvre, C., & Westby, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1191 · Cited by 116 · see citing works
Engers, A. J., Wensing, M., van Tulder, M. W., Timmermans, A., Oostendorp, R. A. B., Koes, B. W., & Grol, R. (2005) · Spine · doi:10.1097/01.brs.0000155406.79479.3a · Cited by 113 · see citing works
Self-citationvan Eijk, M. E. C., Avorn, J., Porsius, A. J., & de Boer, A. (2001) · BMJ · doi:10.1136/bmj.322.7287.654 · Cited by 111 · see citing works
Changing the clinical behavior of doctors: a psychological framework.
Robertson, N., Baker, R., & Hearnshaw, H. (1996) · BMJ Quality & Safety · doi:10.1136/qshc.5.1.51 · Cited by 111 · see citing works
Self-citationSmall group intervention vs formal seminar for improving appropriate drug use
Santoso, B. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00390-8 · Cited by 106 · see citing works
Baker, R., Reddish, S., Robertson, N., Hearnshaw, H., & Jones, B. (2001) · Europe PMC (PubMed Central) · Cited by 105 · see citing works
Self-citationBeeckman, D., Clays, E., Van Hecke, A., Vanderwee, K., Schoonhoven, L., & Verhaeghe, S. (2013) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2012.09.007 · Cited by 100 · see citing works
Hux, J. E., Melady, M. P., & DeBoer, D. P. (1999) · Europe PMC (PubMed Central) · Cited by 100 · see citing works
Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention
Fretheim, A., Oxman, A. D., Håvelsrud, K., Treweek, S., Kristoffersen, D. T., & Bjørndal, A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030134 · Cited by 99 · see citing works
Murphy, A. W., Cupples, M. E., Smith, S. M., Byrne, M., Byrne, M. C., Newell, J., & for the SPHERE study team (2009) · BMJ · doi:10.1136/bmj.b4220 · Cited by 99 · see citing works
Scott, P. A., Meurer, W. J., Frederiksen, S. M., Kalbfleisch, J. D., Xu, Z., Haan, M. N., Silbergleit, R., & Morgenstern, L. B. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70311-3 · Cited by 96 · see citing works
Coenen, S., Van Royen, P., Michiels, B., & Denekens, J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh374 · Cited by 96 · see citing works
Ukoumunne, O. C. (2002) · Statistics in Medicine · doi:10.1002/sim.1330 · Cited by 96 · see citing works
Why does primary care need more implementation research?
Foy, R., Eccles, M., & Grimshaw, J. (2001) · Family Practice · doi:10.1093/fampra/18.4.353 · Cited by 96 · see citing works
Self-citationUnrod, M., Smith, M., Spring, B., DePue, J., Redd, W., & Winkel, G. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0069-0 · Cited by 95 · see citing works
Improving Nursing Home Staff Knowledge and Attitudes About Pain
Jones, K. R., Fink, R. M., Pepper, G., Hutt, E., Vojir, C. P., Scott, J., Clark, L., & Mellis, K. (2004) · The Gerontologist · doi:10.1093/geront/44.4.469 · Cited by 95 · see citing works
Barriers to adequate delivery of hemodialysis
Sehgal, A., Snow, R., Singer, M. E., Amini, S., DeOreo, P. B., Mr, S., & Cebul, R. D. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531174 · Cited by 94 · see citing works
Simon, S. R., Majumdar, S. R., Prosser, L. A., Salem-Schatz, S., Warner, C., Kleinman, K., Miroshnik, I., & Soumerai, S. B. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.023 · Cited by 87 · see citing works
Flottorp, S. A., Håvelsrud, K., & Oxman, A. D. (2003) · Family Practice · doi:10.1093/fampra/cmg316 · Cited by 87 · see citing works
Self-citationTesting a Nurse-Tailored HIV Medication Adherence Intervention
Holzemer, W. L., Henry, S. B., Portillo, C. J., Grimes, R., Welch, J., Wantland, D. J., & Mullan, J. T. (2006) · Nursing Research · doi:10.1097/00006199-200605000-00005 · Cited by 87 · see citing works
Depression of elderly outpatients: Primary care physicians’ attitudes and practice patterns
Callahan, C. M., Nienaber, N. A., Hendrie, H. C., & Tierney, W. M. (1992) · Journal of General Internal Medicine · doi:10.1007/bf02599097 · Cited by 86 · see citing works
Levine, S., Unützer, J., Yip, J. Y., Hoffing, M., Leung, M., Fan, M.-Y., Lin, E. H. B., Grypma, L., Katon, W. J., Harpole, L. H., et al. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.06.001 · Cited by 85 · see citing works
Designing Tailored Web-Based Instruction to Improve Practicing Physicians' Preventive Practices
Casebeer, L. L., Strasser, S. M., Spettell, C. M., Wall, T. C., Weissman, N., Ray, M. N., & Allison, J. J. (2003) · Journal of Medical Internet Research · doi:10.2196/jmir.5.3.e20 · Cited by 85 · see citing works
Cohen‐Mansfield, J., Thein, K., Marx, M. S., & Dakheel‐Ali, M. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.07.006 · Cited by 84 · see citing works
Zimmerman, R. K., Nowalk, M. P., Raymund, M., Tabbarah, M., Hall, D. G., Wahrenberger, J. T., Wilson, S. A., & Ricci, E. M. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.10.1699 · Cited by 81 · see citing works
van de Ven, G., Draskovic, I., Adang, E., Donders, R. A. R. T., Zuidema, S. U., Koopmans, R. T. C. M., & Vernooij-Dassen, M. J. F. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067325 · Cited by 80 · see citing works
Improving Care of Patients At-Risk for Osteoporosis: A Randomized Controlled Trial
Solomon, D. H., Polinski, J. M., Stedman, M. R., Truppo, C., Breiner, L., Egan, C., Jan, S., Patel, M., Weiss, T. W., Chen, Y.-T., et al. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0099-7 · Cited by 79 · see citing works
Zwarenstein, M., Fairall, L. R., Lombard, C., Mayers, P., Bheekie, A., English, R. G., Lewin, S., Bachmann, M. O., & Bateman, E. (2011) · BMJ · doi:10.1136/bmj.d2022 · Cited by 77 · see citing works
Karuza, J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430060089011 · Cited by 77 · see citing works
Tailored implementation of evidence-based practice for patients with chronic diseases
Wensing, M., Huntink, E., van Lieshout, J., Godycki-Cwirko, M., Kowalczyk, A., Jäger, C., Steinhäuser, J., Aakhus, E., Flottorp, S., Eccles, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101981 · Cited by 74 · see citing works
Self-citationSchouten, J. A., Hulscher, M., Liefers, J., Akkermans, R., Kullberg, B. J., Grol, R. P. T. M., & van der Meer, J. W. M. (2007) · Clinical Infectious Diseases · doi:10.1086/512193 · Cited by 73 · see citing works
Improving the Reporting of Adverse Drug Reactions
Herdeiro, M. T., Polónia, J. J., Gestal, J. J., & Figueiras, A. (2008) · Drug Safety · doi:10.2165/00002018-200831040-00007 · Cited by 72 · see citing works
Griffiths, C., Sturdy, P., Brewin, P., Bothamley, G. H., Eldridge, S. M., Martineau, A. R., MacDonald, M., Ramsay, J., Tibrewal, S., Levi, S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60707-7 · Cited by 71 · see citing works
Gülmezoglu, A. M., Langer, A., Piaggio, G. G., Lumbiganon, P., Villar, J., & Grimshaw, J. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01091.x · Cited by 70 · see citing works
Cheater, F. M., Baker, R., Reddish, S., Spiers, N., Wailoo, A., Gillies, C., Robertson, N., & Cawood, C. (2006) · Medical Care · doi:10.1097/01.mlr.0000215919.89893.8a · Cited by 67 · see citing works
Self-citationPreventing unintentional pediatric injuries: a tailored intervention for parents and providers
Nansel, T. R., Weaver, N. L., Jacobsen, H. A., Glasheen, C., & Kreuter, M. W. (2007) · Health Education Research · doi:10.1093/her/cym041 · Cited by 67 · see citing works
van Gaal, B. G. I., Schoonhoven, L., Mintjes, J. A. J., Borm, G. F., Hulscher, M., Defloor, T., Habets, H., Voß, A., Vloet, L. C. M., Koopmans, R. T. C. M., et al. (2011) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2011.02.017 · Cited by 66 · see citing works
Psychoactive medication use in intermediate-care facility residents.
Beers, M. H., Avorn, J., Soumerai, S. B., Everitt, D. E., Sherman, D. S., & Salem, S. (1988) · PubMed · Cited by 66 · see citing works
Multicomponent Internet continuing medical education to promote chlamydia screening
Allison, J. J., Kiefe, C. I., Wall, T. C., Casebeer, L. L., Ray, M. N., Spettell, C. M., Hook, E. W., Oh, M. K., Person, S. D., & Weissman, N. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.12.013 · Cited by 65 · see citing works
Meurer, W. J., Majersik, J. J., Frederiksen, S. M., Kade, A. M., Sandretto, A., & Scott, P. (2011) · BMC Emergency Medicine · doi:10.1186/1471-227x-11-5 · Cited by 64 · see citing works
Disseminating research, changing practice
Dunn, E. V. (1994) · Medical Entomology and Zoology · Cited by 63 · see citing works
Flottorp, S., & Oxman, A. D. (2003) · BMC Health Services Research · doi:10.1186/1472-6963-3-3 · Cited by 62 · see citing works
Self-citationSehgal, A. R., Leon, J. B., Siminoff, L. A., Singer, M. E., Bunosky, L. M., & Cebul, R. D. (2002) · JAMA · doi:10.1001/jama.287.15.1961 · Cited by 62 · see citing works
One-to-One Versus Group Sessions to Improve Prescription in Primary Care
Figueiras, A., Sastre, I., Tato, F., guez, C. R., Lado, E. U., Caamaño‐Isorna, F., & Gestal, J. J. (2001) · Medical Care · doi:10.1097/00005650-200102000-00006 · Cited by 62 · see citing works
Azocar, F., Cuffel, B., Goldman, W., & McCarter, L. (2005) · Journal of Behavioral Health Services & Research · doi:10.1007/bf02287816 · Cited by 61 · see citing works
Improving Cancer Pain Management by Homecare Nurses
Vallerand, A. H., Riley-Doucet, C. K., Hasenau, S. M., & Templin, T. (2004) · Oncology nursing forum · doi:10.1188/04.onf.809-816 · Cited by 57 · see citing works
Economic Impact of Increased Clinical Intervention Rates in Community Pharmacy
Benrimoj, S. I., Langford, J., Berry, G., Collins, D. M., Lauchlan, R. L., Stewart, K., Aristides, M., & Dobson, M. (2000) · PharmacoEconomics · doi:10.2165/00019053-200018050-00005 · Cited by 57 · see citing works
Looijmans-van den Akker, I., van Delden, J. J. M., Verheij, T. J. M., van der Sande, M. A. B., van Essen, G. A., Riphagen-Dalhuisen, J., Hulscher, M. E., & Hak, E. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.003 · Cited by 56 · see citing works
Implementation of locally adapted guidelines on type 2 diabetes
van Bruggen, R., Gorter, K. J., Stolk, R. P., Verhoeven, R. P., & Rutten, G. E. H. M. (2008) · Family Practice · doi:10.1093/fampra/cmn045 · Cited by 55 · see citing works
Straand, J., Fetveit, A., Rognstad, S., Gjelstad, S., Brekke, M., & Dalen, I. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-72 · Cited by 52 · see citing works
Gregory, C., Cifaldi, M., & Tanner, L. A. (1999) · PubMed · Cited by 52 · see citing works
An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids
Leviton, L. C., Baker, S., Hassol, A., & Goldenberg, R. L. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90220-1 · Cited by 51 · see citing works
Montgomery, R. J. V., Kwak, J., Kosloski, K., & Valuch, K. O. (2011) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbr088 · Cited by 50 · see citing works
Velasco, J. A., Cosín, J., de Oya, M., & de Teresa, E. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77077-3 · Cited by 49 · see citing works
Socolar, R. R. S., Raines, B., Chen-Mok, M., Runyan, D. K., Green, C. L., & Paterno, S. M. (1998) · PEDIATRICS · doi:10.1542/peds.101.5.817 · Cited by 46 · see citing works
An interactive videodisc program for low back pain patients
Spunt, B., Deyo, R. A., Taylor, V. M., Leek, K. M., Goldberg, H. I., & Mulley, A. G. (1996) · Health Education Research · doi:10.1093/her/11.4.535 · Cited by 46 · see citing works
Expediting the turnaround of radiology reports in a teaching hospital setting.
Seltzer, S. E., Kelly, P., Adams, D. F., Chiango, B. F., Viera, M. A., Fener, E. F., Hooton, S., Bannon-Rohrbach, S., Healy, C., Doubilet, P. M., et al. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.4.9124134 · Cited by 46 · see citing works
Green, L. A., Gorenflo, D. W., & Wyszewianski, L. (2002) · PubMed · Cited by 46 · see citing works
Patient-Oriented Outcomes From Low Back Surgery
Taylor, V. M., Deyo, R. A., Ciol, M. A., Farrar, E. L., Lawrence, M. S., Shonnard, N. H., Leek, K. M., McNeney, B., & Goldberg, H. I. (2000) · Spine · doi:10.1097/00007632-200010010-00005 · Cited by 46 · see citing works
Foy, R., Penney, G. C., Grimshaw, J. M., Ramsay, C. R., Walker, A. E., MacLennan, G., Stearns, S. C., McKenzie, L., & Glasier, A. (2004) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00168.x · Cited by 44 · see citing works
McNulty, C. A. M., Hogan, A. H., Ricketts, E. J., WALLACE, L. M., Oliver, I., Campbell, R. M., Kalwij, S., O'Connell, E. E., & Charlett, A. (2013) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051029 · Cited by 44 · see citing works
Cupples, M., Byrne, M. C., Smith, S. M., Leathem, C. S., & Murphy, A. W. (2008) · Heart · doi:10.1136/hrt.2008.145912 · Cited by 44 · see citing works
Evaluating Online Continuing Medical Education Seminars: Evidence for Improving Clinical Practices
Weston, C. M., Sciamanna, C., & Nash, D. B. (2008) · American Journal of Medical Quality · doi:10.1177/1062860608325266 · Cited by 43 · see citing works
Outreach Education to Improve Quality of Rural ICU Care: Results of a Randomized Trial
HENDRYX, M. S., Fieselmann, J. F., BOCK, M. J., Wakefield, D. S., Helms, C. M., & Bentler, S. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.2.9608068 · Cited by 43 · see citing works
van Gaal, B. G. I., Schoonhoven, L., Vloet, L. C. M., Mintjes, J. A. J., Borm, G. F., Koopmans, R. T. C. M., & van Achterberg, T. (2010) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2010.02.001 · Cited by 43 · see citing works
van Driel, M., Coenen, S., Dirven, K., Lobbestael, J., Janssens, I., Royen, P. V., Haaijer‐Ruskamp, F. M., Meyere, M. D., Maeseneer, J. D., & Christiaens, T. (2007) · BMJ Quality & Safety · doi:10.1136/qshc.2006.018663 · Cited by 42 · see citing works
Hennessy, S., Leonard, C. E., Yang, W. P., Kimmel, S. E., Townsend, R. R., Wasserstein, A. G., Have, T. R. T., & Bilker, W. B. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.9.1342 · Cited by 41 · see citing works
Peters-Klimm, F., Müller‐Tasch, T., Remppis, A., Szécsényi, J., & Schellberg, D. (2008) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01060.x · Cited by 41 · see citing works
An Educational Intervention to Train Community Pharmacists in Providing Specialized Asthma Care
Saini, B., Smith, L. D., Armour, C. L., & Krass, I. (2006) · American Journal of Pharmaceutical Education · doi:10.5688/aj7005118 · Cited by 40 · see citing works
The SAFE or SORRY? programme. Part II: Effect on preventive care
van Gaal, B. G. I., Schoonhoven, L., Mintjes, J. A. J., Borm, G. F., Koopmans, R. T. C. M., & van Achterberg, T. (2011) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2011.02.018 · Cited by 39 · see citing works
Eccles, M., Steen, I. N., Whitty, P., & Hall, L. (2007) · Implementation Science · doi:10.1186/1748-5908-2-23 · Cited by 39 · see citing works
Self-citationA cluster-randomized trial to improve stroke care in hospitals
Lakshminarayan, K., Borbas, C., McLaughlin, B., Morris, N. E., Vazquez, G., Luepker, R. V., & Anderson, D. C. (2010) · Neurology · doi:10.1212/wnl.0b013e3181df096b · Cited by 38 · see citing works
Kinmonth, A., Spiegal, N., & Woodcock, A. J. (1996) · Patient Education and Counseling · doi:10.1016/0738-3991(96)00936-6 · Cited by 38 · see citing works
Byrne, M., Cupples, M., Smith, S. M., Leathem, C. S., Corrigan, M., Byrne, M. C., & Murphy, A. W. (2006) · PubMed · Cited by 38 · see citing works
Fretheim, A., Oxman, A. D., Treweek, S. P., & Bjørndal, A. (2003) · BMC Health Services Research · doi:10.1186/1472-6963-3-5 · Cited by 37 · see citing works
New, J. P., Mason, J. M., Freemantle, N., Teasdale, S., Wong, L., Bruce, N. J., Burns, J. A., & Gibson, M. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01213.x · Cited by 37 · see citing works
Dizon, J. M. R., Grimmer, K. A., & Kumar, S. (2014) · BMC Medical Education · doi:10.1186/1472-6920-14-147 · Cited by 37 · see citing works
Uebel, K., Fairall, L. R., van Rensburg, D. H., Mollentze, W. F., Bachmann, M. O., Lewin, S. A., Zwarenstein, M., Colvin, C. J., Georgeu-Pepper, D., Mayers, P. M., et al. (2011) · Implementation Science · doi:10.1186/1748-5908-6-86 · Cited by 36 · see citing works
Ward, S. E., Wang, K. K., Serlin, R. C., Peterson, S. L., & Murray, M. E. (2009) · Pain · doi:10.1016/j.pain.2009.02.021 · Cited by 36 · see citing works
Gjelstad, S., Fetveit, A., Straand, J., Dalen, I., Rognstad, S., & Lindbæk, M. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-75 · Cited by 35 · see citing works
Promoting evidence-based medicine in general practice--the impact of academic detailing
Markey, P. G., & Schattner, P. L. (2001) · Family Practice · doi:10.1093/fampra/18.4.364 · Cited by 35 · see citing works
Shirazi, M., Lonka, K., Parikh, S. V., Ristner, G., Alaeddini, F., Sadeghi, M., & Wahlström, R. (2011) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2011.01761.x · Cited by 34 · see citing works
Handsearching versus electronic searching to identify reports of randomized trials
Hopewell, S., Clarke, M. J., Lefebvre, C., & Scherer, R. W. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000001 · Cited by 34 · see citing works
Edwards, K. S. (2002) · Academic Medicine · doi:10.1097/00001888-200209000-00045 · Cited by 33 · see citing works
Davies, B., HODNETT, E. D., Hannah, M., O’Brien‐Pallas, L., Pringle, D. M., & Wells, G. (2002) · PubMed Central · Cited by 33 · see citing works
Witt, K. (2004) · Family Practice · doi:10.1093/fampra/cmh306 · Cited by 32 · see citing works
How to develop a program to increase influenza vaccine uptake among workers in health care settings?
den Akker, I. L., Hulscher, M., Verheij, T. J., Riphagen‐Dalhuisen, J., van Delden, J. J., & Hak, E. (2011) · Implementation Science · doi:10.1186/1748-5908-6-47 · Cited by 32 · see citing works
Cheater, F., Baker, R., Hearnshaw, H., Robertson, N., Hicks, N., Oxman, A., & Flottorp, S. A. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001483 · Cited by 32 · see citing works
Self-citationJansen, Y. J. F. M., Bont, A. A. D., Foets, M., Bruijnzeels, M. A., & Bal, R. A. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-125 · Cited by 31 · see citing works
van Gaal, B. G. I., Schoonhoven, L., Hulscher, M., Mintjes, J. A. J., Borm, G. F., Koopmans, R. T. C. M., & van Achterberg, T. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-58 · Cited by 31 · see citing works
Naughton, C., Feely, J., & Bennett, K. (2007) · Family Practice · doi:10.1093/fampra/cmm044 · Cited by 31 · see citing works
Cranney, M., Barton, S., & Walley, T. (1999) · PubMed · Cited by 31 · see citing works
Improving Influenza Vaccination Rates of High-Risk Inner-City Children Over 2 Intervention Years
Zimmerman, R. K., Hoberman, A., Nowalk, M. P., Lin, C. J., Greenberg, D. P., Weinberg, S. T., Ko, F.-S., & Fox, D. E. (2006) · The Annals of Family Medicine · doi:10.1370/afm.612 · Cited by 30 · see citing works
Hanbury, A., WALLACE, L. M., & Clark, M. (2008) · British Journal of Health Psychology · doi:10.1348/135910708x369558 · Cited by 30 · see citing works
Improving paediatric nurses' knowledge and attitudes in childhood fever management
Edwards, H. E., Walsh, A. M., Courtney, M., Monaghan, S., Wilson, J., & Young, J. (2007) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2006.04077.x · Cited by 30 · see citing works
Murphy, A. W., Cupples, M., Smith, S. M., Byrne, M., Leathem, C. S., & Byrne, M. C. (2005) · Current Controlled Trials in Cardiovascular Medicine · doi:10.1186/1468-6708-6-11 · Cited by 29 · see citing works
Simunovic, M. R. I., Coates, A. J., Goldsmith, C. H., Thabane, L., Reeson, D., Smith, A., McLeod, R. S., DeNardi, F. G., Whelan, T. J., & Levine, M. N. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091883 · Cited by 29 · see citing works
Leong, C. N., Shakespeare, T. P., Mukherjee, R. K., Back, M., Lee, K. M., Lu, J. J., Wynne, C. J., Lim, K. H. C., Tang, J. I.-H., & Zhang, X. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.07.018 · Cited by 29 · see citing works
Voorn, V. M. A., de Mheen, P. J. M., Wentink, M. M., Kaptein, A. A., Gemert, A. W. M. M. K.-V., So‐Osman, C., Vlieland, T. P. M. V., Nelissen, R. G. H. H., van Bodegom‐Vos, L., & LISBOA Study Group (2014) · Transfusion · doi:10.1111/trf.12672 · Cited by 29 · see citing works
Effectiveness of multifaceted implementation of guidelines in primary care
Wright, J., Warren, E., Reeves, J., Bibby, J., Harrison, S. A., Dowswell, G., Russell, I. T., & Russell, D. (2003) · Journal of Health Services Research & Policy · doi:10.1258/135581903322029485 · Cited by 28 · see citing works
Jäger, C., Freund, T., Steinhäuser, J., Joos, S., Wensing, M., & Szécsényi, J. (2013) · Trials · doi:10.1186/1745-6215-14-420 · Cited by 28 · see citing works
Self-citationHuntink, E. M., Heijmans, N., Wensing, M., & van Lieshout, J. (2013) · Trials · doi:10.1186/1745-6215-14-433 · Cited by 28 · see citing works
Self-citationAshford, J., Eccles, M., Bond, S., Hall, J. A., & Bond, J. (1999) · British Journal of Clinical Governance · doi:10.1108/14664109910297146 · Cited by 28 · see citing works
Self-citationHuntink, E., van Lieshout, J., Aakhus, E., Baker, R., Flottorp, S., Godycki-Cwirko, M., Jäger, C., Kowalczyk, A., Szecsenyi, J., & Wensing, M. (2014) · Implementation Science · doi:10.1186/s13012-014-0185-x · Cited by 27 · see citing works
Self-citationBenrimoj, S. I., Langford, J., Ward, P., Berry, G., Collins, D. M., Lauchlan, R. L., & Stewart, K. (2003) · International Journal of Pharmacy Practice · doi:10.1211/0022357021215 · Cited by 27 · see citing works
Barkun, A. N., Bhat, M., Armstrong, D., Dawes, M. G., Donner, A. P., Enns, R., Martin, J. E., Moayyedi, P., Romagnuolo, J., & Stitt, L. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.120095 · Cited by 27 · see citing works
Gask, L. L., Dixon, C., May, C. R., & Dowrick, C. F. (2005) · Europe PMC (PubMed Central) · doi:10.25405/ncl.34618200 · Cited by 27 · see citing works
Langham, J., Tucker, H., Sloan, D., Pettifer, J., Thom, S., & Hemingway, H. (2002) · Europe PMC (PubMed Central) · Cited by 27 · see citing works
Fretheim, A., Oxman, A. D., & Flottorp, S. (2004) · BMC Health Services Research · doi:10.1186/1472-6963-4-23 · Cited by 26 · see citing works
Self-citationVerhoeven, V., Avonts, D., Vermeire, E., Debaene, L., & Royen, P. V. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2004.05.001 · Cited by 26 · see citing works
Chavane, L., Merialdi, M., Betrán, A. P., Requejo, J. H., Bergel, E. F., Alemán, A., Colomar, M., Cafferata, M. L., Carbonell, A., Crahay, B., et al. (2014) · BMC Health Services Research · doi:10.1186/1472-6963-14-228 · Cited by 26 · see citing works
Fairall, L. R., Bachmann, M. O., Zwarenstein, M., Lombard, C. J., Uebel, K., van Vuuren, C., Steyn, D., Boulle, A., & Bateman, E. D. (2008) · Trials · doi:10.1186/1745-6215-9-21 · Cited by 26 · see citing works
Sinnema, H., Franx, G. C., Volker, D., Majo, C., Terluin, B., Wensing, M., & van Balkom, A. J. L. M. (2011) · Implementation Science · doi:10.1186/1748-5908-6-75 · Cited by 26 · see citing works
Self-citationDrew, B. J., Sommargren, C. E., Schindler, D. M., Benedict, K., Zègre‐Hemsey, J. K., & Glancy, J. P. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.09.027 · Cited by 26 · see citing works
Do nursing home residents make greater demands on GPs? A prospective comparative study.
Pell, J. P., & Williams, S. (1999) · Europe PMC (PubMed Central) · Cited by 26 · see citing works
Muñiz, J., Gómez‐Doblas, J. J., Santiago-Pérez, M. I., Galván, E. D. T., Fernández, J. M. C., & Beiras, A. C. (2004) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60187-4 · Cited by 26 · see citing works
Dixon, B. E., Grannis, S. J., & Debra Revere, A. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-121 · Cited by 25 · see citing works
Bosch, M., McKenzie, J. E., Mortimer, D., Tavender, E. J., Francis, J., Brennan, S., Knott, J. C., Ponsford, J. L., Pearce, A. P., O’Connor, D. A., et al. (2014) · Trials · doi:10.1186/1745-6215-15-281 · Cited by 25 · see citing works
The cost-effectiveness of integrated home care and discharge practice for home care patients
Hammar, T., Rissanen, P., & Perälä, M. (2009) · Health Policy · doi:10.1016/j.healthpol.2009.02.002 · Cited by 24 · see citing works
Barker, A. L., Brand, C. A., Haines, T. P., Hill, K., Brauer, S., Jolley, D., Botti, M. A., Cumming, R. G., Livingston, P. M., Sherrington, C., et al. (2011) · Injury Prevention · doi:10.1136/injuryprev-2011-040074 · Cited by 24 · see citing works
Lobo, C. M., Frijling, B. D., Hulscher, M., Bernsen, R. M. D., Grol, R. P. T. M., Prins, A., & van der Wouden, J. C. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000015285.08673.42 · Cited by 23 · see citing works
Wright, J. (2006) · BMJ Quality & Safety · doi:10.1136/qshc.2005.014704 · Cited by 23 · see citing works
Zwarenstein, M., Bheekie, A., Lombard, C., Swingler, G., Ehrlich, R., Eccles, M., Sladden, M., Pather, S., Grimshaw, J., & Oxman, A. D. (2007) · Implementation Science · doi:10.1186/1748-5908-2-30 · Cited by 22 · see citing works
Self-citationDoes the world need a scientific society for research on how to improve healthcare?
Wensing, M., Grimshaw, J. M., & Eccles, M. P. (2012) · Implementation Science · doi:10.1186/1748-5908-7-10 · Cited by 22 · see citing works
Self-citationShirazi, M., zeinaloo, A. A., Parikh, S. V., Sadeghi, M., Taghva, A., Arbabi, M., Kashani, A. S., Alaeddini, F., Lonka, K., & Wahlström, R. (2008) · Family Practice · doi:10.1093/fampra/cmn008 · Cited by 22 · see citing works
Multifaceted intervention to promote β-blocker use in heart failure
LaPointe, N. M. A., DeLong, E. R., Chen, A., Hammill, B. G., Muhlbaier, L. H., Califf, R. M., & Kramer, J. M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.038 · Cited by 20 · see citing works
COMBINING FEEDBACK FROM SIMULATED CASES AND PRESCRIBING
Lundborg, C. S., Wahlström, R., Diwan, V. K., Oké, T., Mårtenson, D., & Tomson, G. B. (1999) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462399315324 · Cited by 20 · see citing works
Godycki-Ćwirko, M., Zakowska, I., Kosiek, K., Wensing, M., Krawczyk, J., & Kowalczyk, A. (2014) · Trials · doi:10.1186/1745-6215-15-109 · Cited by 19 · see citing works
Self-citationKrause, J., Agarwal, S., Bodicoat, D. H., Ring, A., Shepherd, D. J., Rogers, S., Wensing, M., & Baker, R. (2014) · Trials · doi:10.1186/1745-6215-15-82 · Cited by 19 · see citing works
Self-citationAakhus, E., Granlund, I., Odgaard‐Jensen, J., Wensing, M., Oxman, A. D., & Flottorp, S. A. (2014) · Trials · doi:10.1186/1745-6215-15-16 · Cited by 18 · see citing works
Self-citationAcademic Detailing to Improve Laboratory Testing Among Outpatient Medication Users
Lafata, J. E., Gunter, M. J., Hsu, J. T.-A., Kaatz, S. S., Krajenta, R. J., Platt, R. G., Schultz, L. R., Selby, J. V., Simon, S. R., Simpkins, J., et al. (2007) · Medical Care · doi:10.1097/mlr.0b013e3180546856 · Cited by 18 · see citing works
Dizon, J. M. R., Grimmer, K. A., & Kumar, S. (2011) · BMC Medical Education · doi:10.1186/1472-6920-11-14 · Cited by 17 · see citing works
Matchar, D. B., Samsa, G. P., Cohen, S. J., & Oddone, E. Ž. (2000) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1018722001817 · Cited by 16 · see citing works
Flagged first, then by citations
Research works printed but not linked: 9
- Samsa, 1998, A seven step model for practice improvement research: description and application to the managing anticoagulation services trial, New Medicine, 2, 139
- Fretheim, 2004, Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change, BMC Health Services Research, 4, 23, 10.1186/1472-6963-4-23 · DOI · Paper page
- Murphy, 2005, The SPHERE study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses, Current Controlled Trials in Cardiovascular Medicine, 6, 11, 10.1186/1468-6708-6-11 · DOI
- Cochrane Effective Practice and Organisation of Care Group: Data Collection Checklist EPOC resources for review authors (http://www.epoc.cochrane.org/en/handsearchers.html) Revised 2002
- Cochrane Effective Practice and Organisation of Care Group, 2014, What outcomes should be reported in EPOC reviews?
- Institute for Clinical Effectiveness and Health Policy Early Review Organizing Software (EROS) 2009
- Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org
- Lomas, 1994, Teaching old (and not so old) dogs new tricks: effective ways to implement research findings, 1
- Légaré, 2009, Assessing barriers and facilitators to knowledge use, 83
Cited by
Sorted by citations
Atkins, L., Francis, J., Islam, R., O’Connor, D., Patey, A., Ivers, N., Foy, R., Duncan, E. M., Colquhoun, H., Grimshaw, J. M., et al. (2017) · Implementation Science · doi:10.1186/s13012-017-0605-9 · Cited by 3,819 · see citing works
“Despite this, systematic reviews of interventions designed to change professional practice have shown only small numbers of rigorous evaluations reporting the use of theory to assess implementation problems or guide intervention design [8, 13, 14].”
BackgroundWaltz, T. J., Powell, B. J., Fernández, M. E., Abadie, B., & Damschroder, L. J. (2019) · Implementation Science · doi:10.1186/s13012-019-0892-4 · Cited by 1,136 · see citing works
“Results from a systematic literature review [16] concluded that tailored implementation strategies:”
BackgroundEnhancing the Impact of Implementation Strategies in Healthcare: A Research Agenda
Powell, B. J., Fernandez, M. E., Williams, N. J., Aarons, G. A., Beidas, R. S., Lewis, C. C., McHugh, S. M., & Weiner, B. J. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00003 · Cited by 775 · see citing works
“strategies (37) 32 RCTs Meta-regression using 15 randomized trials.”
BackgroundMethodInfluentialJohnson, M. J., & May, C. R. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008592 · Cited by 512 · see citing works
“Austin 1994[4] Yes Unclear No No No Yes No No Yes No No 3”
BackgroundGeerligs, L., Rankin, N. M., Shepherd, H. L., & Butow, P. N. (2018) · Implementation Science · doi:10.1186/s13012-018-0726-9 · Cited by 495 · see citing works
“While much research in implementation science has focused on the contextual factors such as system and staff influences, recent research has highlighted this important role that intervention design plays in implementation processes [63].”
BackgroundBirken, S. A., Powell, B. J., Presseau, J., Kirk, M. A., Lorencatto, F., Gould, N. J., Shea, C. M., Weiner, B. J., Francis, J., Yu, Y., et al. (2017) · Implementation Science · doi:10.1186/s13012-016-0534-z · Cited by 387 · see citing works
Reflections on 10 years of effectiveness-implementation hybrid studies
Curran, G. M., Landes, S. J., McBain, S. A., Pyne, J. M., Smith, J. D., Fernandez, M. E., Chambers, D. A., & Mittman, B. S. (2022) · Frontiers in Health Services · doi:10.3389/frhs.2022.1053496 · Cited by 299 · see citing works
Forsetlund, L., O’Brien, M. A., Forsén, L., Mwai, L., Reinar, L. M., Okwen, P., Horsley, T., & Rose, C. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003030.pub3 · Cited by 293 · see citing works
Tomás Pantoja, C., Opiyo, N., Lewin, S. A., Paulsen, E., Ciapponi, A., Wiysonge, C. S., Herrera, C. A., Gabriel Rada, G., Peñaloza, B., Dudley, L., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011086.pub2 · Cited by 258 · see citing works
Simulation-based training for nurses: Systematic review and meta-analysis
Hegland, P. A., Aarlie, H., Strømme, H., & Jamtvedt, G. (2017) · Nurse Education Today · doi:10.1016/j.nedt.2017.04.004 · Cited by 205 · see citing works
Costa, D. K., White, M. R., Capellari, E. C., Manojlovich, M., Govindan, S., Iwashyna, T. J., & Sales, A. E. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.03.054 · Cited by 181 · see citing works
Schloemer, T., & Schröder‐Bäck, P. (2018) · Implementation Science · doi:10.1186/s13012-018-0751-8 · Cited by 178 · see citing works
Arditi, C., Rège-Walther, M., Wyatt, J. C., Durieux, P., & Burnand, B. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001175.pub3 · Cited by 172 · see citing works
Implementation science in resource-poor countries and communities
Yapa, H. M., & Bärnighausen, T. (2018) · Implementation Science · doi:10.1186/s13012-018-0847-1 · Cited by 170 · see citing works
“The 18 systematic reviews on different strategies to change health worker behavior in this overview article—education materials [40], internet-based learning [41], educational meetings and workshops [42–45], educational outreach [46–48], local opinion leaders [49], audit and feedback [50], reminders [51], tailored int…”
BackgroundHoffmann-Eßer, W., Siering, U., Neugebauer, E. A. M., Brockhaus, A. C., Lampert, U., & Eikermann, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174831 · Cited by 171 · see citing works
Hoben, M., Clarke, A., Huynh, K. T., Kobagi, N., Kent, A., Hu, H., Pereira, R. A. C., Xiong, T., Yu, K., Xiang, H., et al. (2017) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2017.05.003 · Cited by 168 · see citing works
“…in nursing homes is lacking (Albrecht et al., 2016; Coker et al., 2014; de LugtLustig et al., 2014; Weening-Verbree et al., 2013), and tailoring interventions to barriers and facilitators is crucial to achieve desired change (Baker et al., 2015; Bartholomew et al., 2011; Hulscher et al., 2013).”
BackgroundTrends in guideline implementation: an updated scoping review
Peters, S., Sukumar, K., Blanchard, S., Ramasamy, A., Malinowski, J. R., Ginex, P., Senerth, E., Corremans, M., Munn, Z., Kredo, T., et al. (2022) · Implementation Science · doi:10.1186/s13012-022-01223-6 · Cited by 166 · see citing works
Varsi, C., Solberg Nes, L., Kristjansdottir, O. B., Kelders, S. M., Stenberg, U., Zangi, H. A., Børøsund, E., Weiss, K. E., Stubhaug, A., Asbjørnsen, R. A., et al. (2019) · Journal of Medical Internet Research · doi:10.2196/14255 · Cited by 148 · see citing works
Tools developed and disseminated by guideline producers to promote the uptake of their guidelines
Flodgren, G., Hall, A. M., Goulding, L., Eccles, M., Grimshaw, J., Leng, G. C., & Shepperd, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010669.pub2 · Cited by 159 · see citing works
Self-citationBoyd, M. R., Powell, B. J., Endicott, D., & Lewis, C. C. (2018) · Behavior Therapy · doi:10.1016/j.beth.2017.11.012 · Cited by 137 · see citing works
“There is emerging evidence of the effectiveness of multifaceted and tailored implementation strategies (Baker et al., 2015; Grimshaw, Eccles, Lavis, Hill, & Squires, 2012; Novins, Green, Legha, & Aarons, 2013; Powell, Proctor, & Glass, 2014).”
BackgroundResultInfluentialBunce, A., Gruß, I., Davis, J. V., Cowburn, S., Cohen, D. J., Oakley, J., & Gold, R. B. (2020) · Implementation Science · doi:10.1186/s13012-020-01048-1 · Cited by 145 · see citing works
“better approaches to selecting and operationalizing implementation strategies suitable to a given context [2, 5, 9, 11, 15, 26].”
BackgroundHagermoser Sanetti, L. M., & Collier-Meek, M. A. (2019) · Journal of School Psychology · doi:10.1016/j.jsp.2019.07.008 · Cited by 129 · see citing works
The Tailored Implementation in Chronic Diseases (TICD) project: introduction and main findings
Wensing, M. (2017) · Implementation Science · doi:10.1186/s13012-016-0536-x · Cited by 111 · see citing works
Self-citationFontaine, G., Vinette, B., Weight, C., Maheu‐Cadotte, M., Lavallée, A., Deschênes, M., Lapierre, A., Castiglione, S. A., Chicoine, G., Rouleau, G., et al. (2024) · Implementation Science · doi:10.1186/s13012-024-01398-0 · Cited by 142 · see citing works
“This suggests that strategies customized to address specific barriers and facilitators within a particular context, echoing a previous systematic review by Baker et al., [97] may be more effective in driving improvements in patient care.”
Lewis, C. C., Scott, K., & Marriott, B. R. (2018) · Implementation Science · doi:10.1186/s13012-018-0761-6 · Cited by 113 · see citing works
“Tailoring strategies to the contextual factors that influence the implementation process is touted as critical to achieving success [3, 4]; however, few concrete examples”
BackgroundLin, F. F., Wu, Z., Song, B., Coyer, F. M., & Chaboyer, W. P. (2019) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2019.103483 · Cited by 122 · see citing works
Ritchie, M. J., Parker, L. E., Edlund, C. N., & Kirchner, J. E. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2217-0 · Cited by 112 · see citing works
“Facilitators also assessed the organizational context and current practices and tailored implementation efforts to site context and needs, activities that evidence suggests will improve implementation [25, 70, 71].”
BackgroundLevac, D. E., Glegg, S., Sveistrup, H., Colquhoun, H. L., Miller, P. A., Finestone, H. M., DePaul, V. G., Harris, J. E., & Velikonja, D. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1807-6 · Cited by 109 · see citing works
A checklist to improve health system resilience to infectious disease outbreaks and natural hazards
Meyer, D., Bishai, D. M., Ravi, S., Rashid, H., Mahmood, S. S., Toner, E. S., & Nuzzo, J. B. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-002429 · Cited by 109 · see citing works
Shanbhag, D., Graham, I. D., Harlos, K., Haynes, R. B., Gabizon, I., Connolly, S. J., & Spall, H. G. C. V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-017765 · Cited by 105 · see citing works
“An extensive review by Grimshaw et al concluded that while multifaceted interventions are not inherently more effective than single interventions, they may be more effective when built on a comprehensive assessment of barriers.(60) 69 70 Among the studies on multifaceted interventions in our review, the four studies t…”
BackgroundPotthoff, S., Finch, T. L., Bührmann, L., Etzelmüller, A., van Genugten, C., Girling, M., May, C. R., Perkins, N., Vis, C., & Rapley, T. (2023) · Health Expectations · doi:10.1111/hex.13808 · Cited by 104 · see citing works
“The model is also in line with the idea of contextual integration and tailored implementation.(42) This work recognises that for an implementation strategy to be successful, it needs to be adapted and consider site‐, organisation‐ or group‐specific contextual issues.”
MethodArditi, C., Rège-Walther, M., Durieux, P., & Burnand, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001175.pub4 · Cited by 95 · see citing works
Stokes, T., Shaw, E. J., Camosso‐Stefinovic, J., Imamura, M., Kanguru, L., & Hussein, J. (2016) · Implementation Science · doi:10.1186/s13012-016-0508-1 · Cited by 93 · see citing works
“It is increasingly recognised that for guideline implementation strategies to be effective, we need to better understand why guideline implementation strategies work in some contexts and not in others [5] and also how we can ensure that they have an effect on quality improvement that lasts beyond the duration of any i…”
BackgroundSelf-citationHarris, M. A. (2018) · Health Psychology Open · doi:10.1177/2055102917753853 · Cited by 94 · see citing works
Dyson, J., & Cowdell, F. (2021) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzab106 · Cited by 90 · see citing works
Hand Hygiene Teaching Strategies among Nursing Staff: A Systematic Review
Martos-Cabrera, M. B., Mota‐Romero, E., García, R. M., Gómez‐Urquiza, J. L., Suleiman‐Martos, N., Albendín‐García, L., & la Fuente, G. A. C. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173039 · Cited by 84 · see citing works
“However, some systematic reviews have shown that tailored interventions addressing the determinants of practice improve hand hygiene compliance [53,54].”
BackgroundLewis, C. C., Powell, B. J., Brewer, S. K., Nguyen, A. M., Schriger, S. H., Vejnoska, S., Walsh‐Bailey, C., Aarons, G. A., Beidas, R. S., Lyon, A. R., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053474 · Cited by 82 · see citing works
Acute oxygen therapy: a review of prescribing and delivery practices
McDonald, V. M., Cousins, J. L., & Wark, P. A. B. (2016) · International Journal of COPD · doi:10.2147/copd.s103607 · Cited by 80 · see citing works
Stander, J., Grimmer, K. A., & Brink, Y. (2018) · BMC Medical Education · doi:10.1186/s12909-018-1121-6 · Cited by 79 · see citing works
“Passive, single strategy studies reported non-significant outcomes, with dissemination of CPGs through leaflets being least effective [3, 39, 41].”
BackgroundRohrbasser, A., Harris, J., Mickan, S. M., Tal, K., & Wong, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202616 · Cited by 78 · see citing works
“We do not yet know which techniques should be used or what circumstances encourage QC participants to change their behaviour [52].”
BackgroundHossain, L. N., Fernández-Llimós, F., Luckett, T., Moullin, J. C., Durks, D., Franco-Trigo, L., Benrimoj, S. I., & Sabater‐Hernández, D. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015471 · Cited by 78 · see citing works
“Thus, once elements have been identified for a specific context, further efforts are required to prioritise those elements that are most relevant and can be practically addressed.(8) 65 In this regard, McMillan et al(66) provide a summary of methods used to determine priorities and how they have been used in pharmacy…”
IJsbrandy, C., Hermens, R., Boerboom, L. W. M., Gerritsen, W. R., van Harten, W. H., & Ottevanger, P. B. (2019) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-00789-3 · Cited by 76 · see citing works
“Recent studies in other patient groups show no consistent evidence for the effectiveness of multifaceted strategies (with, for example, combinations of communication, partnership, environmental strategies, social marketing, partnership with policy and environmental improvements) in increasing the “uptake of physical a…”
BackgroundMethodKormelinck, C. M. G., Janus, S. I. M., Smalbrugge, M., Gerritsen, D. L., & Zuidema, S. U. (2020) · International Psychogeriatrics · doi:10.1017/s1041610220000034 · Cited by 78 · see citing works
Vlaeyen, E., Stas, J., Leysens, G., der Elst, E. V., Janssens, E., Dejaeger, E. W., Dobbels, F., & Milisen, K. (2017) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2017.02.002 · Cited by 76 · see citing works
Watkins, K., Wood, H. A., Schneider, C. R., & Clifford, R. M. (2015) · Implementation Science · doi:10.1186/s13012-015-0337-7 · Cited by 75 · see citing works
“However, methodology on how to determine barriers and how to design strategies to address them, is less clear [17, 18].”
BackgroundEffectiveness of Targeted Interventions on Treatment of Infants With Bronchiolitis
Haskell, L., Tavender, E. J., Wilson, C. L., O’Brien, S., Babl, F. E., Borland, M. L., Cotterell, E., Schembri, R., Orsini, F., Sheridan, N., et al. (2021) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2021.0295 · Cited by 74 · see citing works
“Medical inpatient pediatrics 17 (13-30) 17 (11-20)”
Cormican, A., Hirani, S. P., & McKeown, E. (2022) · Clinical Rehabilitation · doi:10.1177/02692155221141036 · Cited by 74 · see citing works
“Tailored multicomponent implementation strategies addressing perceived barriers in local contexts remain wanting despite their evidence in eliciting change in clinical practice.(66,72,73,76,85,86) Only three studies in this review(52,58,66) investigated potential barriers and facilitators pre-implementation to design…”
BackgroundObiezu‐Umeh, C., Nwaozuru, U., Mason, S., Gbaja-Biamila, T. A., Oladele, D. A., Ezechi, O., & Iwelunmor, J. (2021) · Frontiers in Reproductive Health · doi:10.3389/frph.2021.684081 · Cited by 72 · see citing works
“Thus, the use of implementation strategies could be effective in improving processes and outcomes, especially when tailored to different implementation contexts (21, 29, 30).”
BackgroundBoadu, N. Y., Amuasi, J., Ansong, D., Einsiedel, E. F., Menon, D., & Yanow, S. K. (2016) · Malaria Journal · doi:10.1186/s12936-016-1174-0 · Cited by 69 · see citing works
“Widely used approaches that may help to overcome guideline implementation barriers include training, print material and self-audit [48, 49].”
BackgroundVogel, J. P., Moore, J. E., Timmings, C., Khan, S., Khan, D. N., Defar, A., Hadush, A., Terefe, M. M., Teshome, L., Ba‐Thike, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160020 · Cited by 66 · see citing works
“A 2015 Cochrane review by Baker and colleagues included cluster-randomized trials on the use of ‘tailored’ interventions (selection of interventions based on identified determinants of practice) to improve professional practice and healthcare outcomes, including guideline adherence.[33] They reported that tailored imp…”
BackgroundPromoting Hand Hygiene Compliance: PSYGIENE
von Lengerke, T., Lutze, B., Krauth, C., Lange, K., Stahmeyer, J. T., & Chaberny, I. F. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0029 · Cited by 67 · see citing works
Majid, U., Kim, C., Cako, A., & Gagliardi, A. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209826 · Cited by 68 · see citing works
Flodgren, G., Gonçalves, D. C., & Summerbell, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000984.pub3 · Cited by 65 · see citing works
von Lengerke, T., Ebadi, E., Schock, B., Krauth, C., Lange, K., Stahmeyer, J. T., & Chaberny, I. F. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0507-5 · Cited by 64 · see citing works
“Following the recent Cochrane review [32], tailored interventions were defined as planned measures to improve professional practice which take account of prospectively identified determinants of practice.”
BackgroundInfluentialThe complexity of implementation factors in professional pharmacy services
García‐Cárdenas, V., Pérez-Escamilla, B., Fernández-Llimós, F., & Benrimoj, S. I. (2017) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2017.05.016 · Cited by 65 · see citing works
Papoutsakis, C., Moloney, L. M., Sinley, R. C., Acosta, A., Handu, D., & Steiber, A. L. (2016) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2016.07.011 · Cited by 60 · see citing works
Conceptual tensions and practical trade-offs in tailoring implementation interventions
McHugh, S., Riordan, F., Curran, G. M., Lewis, C. C., Wolfenden, L., Presseau, J., Lengnick‐Hall, R., & Powell, B. J. (2022) · Frontiers in Health Services · doi:10.3389/frhs.2022.974095 · Cited by 56 · see citing works
“Tailoring strategies is part of an effort to exact change through determinant-strategy alignment and increase implementation success (9, 10).”
Backgroundthe members of the Guidelines International Network Implementation Working Group, Vernooij, R. W. M., Willson, M. L., & Gagliardi, A. R. (2015) · Implementation Science · doi:10.1186/s13012-016-0419-1 · Cited by 56 · see citing works
“Thus further research is required to understand how guideline implementation can be optimized [5, 6].”
BackgroundImplementing early mobilisation in the intensive care unit: An integrative review
Phelan, S., Lin, F. F., Mitchell, M. L., & Chaboyer, W. P. (2017) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2017.09.019 · Cited by 57 · see citing works
on behalf of the YCR BCIP Study Group, Brown, P. J., Rossington, H., Taylor, J., Lambregts, D. M. J., Morris, E. J. A., West, N. P., Quirke, P., & Tolan, D. J. M. (2019) · European Radiology · doi:10.1007/s00330-019-06028-8 · Cited by 57 · see citing works
“Unlike the study by Siddiqui et al, the existing use of the template reports in two centres (by nine radiologists) eliminates the potential bias arising from the introduction and associated training with template reports when assessing their impact [26, 33].”
Changing prescribing behaviours with educational outreach: an overview of evidence and practice
Kunstler, B., Lennox, A., & Bragge, P. (2019) · BMC Medical Education · doi:10.1186/s12909-019-1735-3 · Cited by 57 · see citing works
Powell, B. J., Patel, S. V., Haley, A. D., Haines, E. R., Knocke, K., Chandler, S., Katz, C. C., Seifert, H. T. P., Ake, G. S., Amaya-Jackson, L. M., et al. (2019) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-019-01003-3 · Cited by 63 · see citing works
“Each of the determinants identified is a potential target for implementation strategies (Baker et al. 2015; Powell et al. 2015, Powell et al. 2017a), though some are likely to be more malleable than others.”
BackgroundEbben, R. H. A., Siqeca, F., Madsen, U. R., Vloet, L. C. M., & van Achterberg, T. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-017572 · Cited by 58 · see citing works
Use of Intervention Mapping to Enhance Health Care Professional Practice: A Systematic Review
Durks, D., Fernandez-Llimos, F., Hossain, L. N., Franco-Trigo, L., Benrimoj, S. I., & Sabater-Hernández, D. (2017) · Health Education & Behavior · doi:10.1177/1090198117709885 · Cited by 59 · see citing works
Cough Augmentation Techniques in the Critically Ill: A Canadian National Survey
Rose, L., Adhikari, N. K. J., Poon, J., Leasa, D. J., Mckim, D. A., the CANuVENT Group, Amin, R., Avendano, M., Dial, S., Fan, E., et al. (2016) · Respiratory Care · doi:10.4187/respcare.04775 · Cited by 54 · see citing works
“Recent thoracic or abdominal surgery 19 (43) 28 (62) 17 (32) 21 (31)”
Lovero, K. L., Kemp, C. G., Wagenaar, B. H., Giusto, A., Greene, M. C., Powell, B. J., & Proctor, E. K. (2023) · Implementation Science · doi:10.1186/s13012-023-01310-2 · Cited by 52 · see citing works
Mathijssen, E. G. E., van den Bemt, B. J. F., Wielsma, S., van den Hoogen, F. H. J., & Vriezekolk, J. E. (2020) · RMD Open · doi:10.1136/rmdopen-2019-001121 · Cited by 54 · see citing works
Cahill, L. S., Carey, L. M., Lannin, N. A., Turville, M. L., Neilson, C., Lynch, E. A., McKinstry, C., Han, J. X., & O’Connor, D. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012575.pub2 · Cited by 51 · see citing works
Low‐value care in musculoskeletal health care: Is there a way forward?
Hartvigsen, J., Kamper, S. J., & French, S. D. (2022) · Pain Practice · doi:10.1111/papr.13142 · Cited by 51 · see citing works
Schoffelen, T., Papan, C., Carrara, E., Eljaaly, K., Paul, M., Keuleyan, E. E., Martín‐Quirós, A., Peiffer‐Smadja, N., Palos, C., May, L. S., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.05.014 · Cited by 53 · see citing works
Powell, B. J., Haley, A. D., Patel, S. V., Amaya-Jackson, L. M., Glienke, B., Blythe, M., Lengnick‐Hall, R., McCrary, S., Beidas, R. S., Lewis, C. C., et al. (2020) · Implementation Science Communications · doi:10.1186/s43058-020-00009-5 · Cited by 50 · see citing works
“, dissemination of guidelines or educational materials) [13], whereas this study sets the stage for a larger trial that would compare COAST-IS to a learning collaborative, a real-world approach adopted by an increasing number of organizations.”
InfluentialBührmann, L., Schuurmans, J., Ruwaard, J., Fleuren, M. A. H., Etzelmueller, A., Piera-Jiménez, J., Finch, T. L., Rapley, T., Potthoff, S., Aouizerate, B., et al. (2020) · Trials · doi:10.1186/s13063-020-04686-4 · Cited by 51 · see citing works
Wan, C. S., Cheng, H., Musgrave‐Takeda, M., Liu, M., Tobiano, G., McMahon, J., & McInnes, E. (2023) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2023.104557 · Cited by 57 · see citing works
Implementation research in emergency medicine: a systematic scoping review
Tavender, E. J., Bosch, M., Fiander, M., Knott, J. C., Gruen, R. L., & O’Connor, D. A. (2015) · Emergency Medicine Journal · doi:10.1136/emermed-2015-205053 · Cited by 51 · see citing works
Self-citationHeus, P., van Dulmen, S. A., Weenink, J.-W., Naaktgeboren, C. A., Takada, T., Verkerk, E. W., Kamm, I., van der Laan, M. J., Hooft, L., & Kool, R. B. (2023) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000392 · Cited by 49 · see citing works
“It has been suggested that for changing behavior, it is not the number or type of interventions that matters, but the fact that an implementation strategy is context-specific and addresses existing influencing factors.(2,40-42) We identified relatively few studies that reported how assessment of barriers and facilitat…”
BackgroundLevac, D. E., Glegg, S., Sveistrup, H., Colquhoun, H. L., Miller, P. A., Finestone, H. M., DePaul, V. G., Harris, J. E., & Velikonja, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168311 · Cited by 49 · see citing works
Mielke, J., Geest, S. D., Zúñiga, F., Brunkert, T., Zullig, L. L., Pfadenhauer, L. M., & Staudacher, S. (2022) · Frontiers in Health Services · doi:10.3389/frhs.2022.953731 · Cited by 47 · see citing works
“, nudging using restrictions on other areas of public life, which may have led to increased anti-COVID-19 vaccination sentiment) (51, 52).”
BackgroundTomsic, I., Heinze, N. R., Chaberny, I. F., Krauth, C., Schock, B., & von Lengerke, T. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-4995-z · Cited by 50 · see citing works
Kovacs, E., Strobl, R., Phillips, A., Stephan, A., Müller, M., Gensichen, J. S., & Grill, E. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4435-5 · Cited by 47 · see citing works
Smith, D., Cartwright, M., Dyson, J., Hartin, J., & Aitken, L. M. (2021) · Journal of Advanced Nursing · doi:10.1111/jan.14830 · Cited by 46 · see citing works
Lin, I. B., Coffin, J., & O’Sullivan, P. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0441-z · Cited by 46 · see citing works
“A recent systematic review compared systematic tailored research translation strategies to untailored interventions in 15 randomised controlled trials, concluding that tailored approaches were more likely to improve practice [25].”
BackgroundSupportive Care: Time to Change Our Prognostic Tools and Their Use in CKD
Couchoud, C., Hemmelgarn, B. R., Kotanko, P., Germain, M. J., Moranne, O. P., & Davison, S. N. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12631115 · Cited by 46 · see citing works
Bosch, M., McKenzie, J. E., Ponsford, J. L., Turner, S., Chau, M., Tavender, E. J., Knott, J. C., Gruen, R. L., Francis, J., Brennan, S., et al. (2019) · Implementation Science · doi:10.1186/s13012-018-0841-7 · Cited by 46 · see citing works
“These implementation strategies may be more effective if they are underpinned by theories of behaviour change and consider the context and determinants of practice (both barriers to and enhancers of the recommended practice) [17, 18].”
BackgroundChanging healthcare professionals' non-reflective processes to improve the quality of care
Potthoff, S., Kwaśnicka, D., Avery, L., Finch, T. L., Gardner, B., Hankonen, N. E., Johnston, D. W., Johnston, M., Kok, G., Lally, P. J., et al. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.114840 · Cited by 47 · see citing works
Vis, C., Schuurmans, J., Aouizerate, B., Craggs, M. A., Batterham, P. J., Bührmann, L., Calear, A. L., Pashoja, A. C., Christensen, H. M., Dozeman, E., et al. (2022) · Journal of Medical Internet Research · doi:10.2196/41532 · Cited by 42 · see citing works
“These findings fit the general pattern across tailoring studies [27].”
InfluentialJäger, C., Freund, T., Steinhäuser, J., Stock, C., Krisam, J., Kaufmann-Kolle, P., Wensing, M., & Szécsényi, J. (2017) · Implementation Science · doi:10.1186/s13012-016-0535-y · Cited by 43 · see citing works
“” Tailored programs are programs explicitly designed to address such previously identified determinants [36].”
BackgroundSelf-citationTrebilcock, M., Worrall, L. E., Ryan, B., Shrubsole, K., Jagoe, C., Simmons‐Mackie, N. N., Bright, F. A. S., Cruice, M. N., Pritchard, M., & Dorze, G. L. (2019) · Aphasiology · doi:10.1080/02687038.2019.1602860 · Cited by 45 · see citing works
“These findings will enable the development of an implementation intervention tailored to specific contextual and individual challenges (Baker et al., 2015).”
BackgroundRiordan, F., Racine, E., Phillip, E. T., Bradley, C., Lorencatto, F., Murphy, M. E., Murphy, A., Browne, J. P., Smith, S. M., Kearney, P. M., et al. (2020) · Implementation Science · doi:10.1186/s13012-020-00982-4 · Cited by 46 · see citing works
Haskell, L., Tavender, E. J., Wilson, C. L., Babl, F. E., Oakley, E. A., Sheridan, N., & Dalziel, S. R. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-02092-y · Cited by 44 · see citing works
Renolen, Å., Høye, S., Hjälmhult, E., Danbolt, L. J., & Kirkevold, M. (2017) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2017.09.006 · Cited by 45 · see citing works
Enhanced Recovery After Surgery
Pearsall, E. A., & McLeod, R. S. (2018) · Surgical Clinics of North America · doi:10.1016/j.suc.2018.07.007 · Cited by 43 · see citing works
A pilot study comparing tools for tracking implementation strategies and treatment adaptations
Walsh‐Bailey, C., Palazzo, L. G., Jones, S. M. W., Mettert, K. D., Powell, B. J., Stirman, S. W., Lyon, A. R., Rohde, P., & Lewis, C. C. (2021) · Implementation Research and Practice · doi:10.1177/26334895211016028 · Cited by 42 · see citing works
“Mounting evidence suggests that tailoring implementation strategies, which involves assessing relevant determinants and designing the strategy to address key determinants and stakeholder needs in a given context, may be more effective than standardized approaches (Baker et al., 2015; Kilbourne et al., 2014; Kirchner e…”
BackgroundImproving the quality of nursing documentation at a residential care home: a clinical audit
Moldskred, P. S., Snibsøer, A. K., & Espehaug, B. (2021) · BMC Nursing · doi:10.1186/s12912-021-00629-9 · Cited by 42 · see citing works
“Page 5/13 We designed a multifaceted implementation strategy (23), with interventions tailored to feedback (24), printed educational materials (25) and local opinion leaders (26).”
MethodA research agenda to advance the study of implementation mechanisms
Lewis, C. C., Frank, H. E., Cruden, G., Kim, B., Stahmer, A. C., Lyon, A. R., Albers, B., Aarons, G. A., Beidas, R. S., Mittman, B. S., et al. (2024) · Implementation Science Communications · doi:10.1186/s43058-024-00633-5 · Cited by 45 · see citing works
“Evidence suggests that tailored implementation may be superior to standardized approaches [22, 23], but tailoring in the absence of understanding strategy mechanisms may compromise outcomes for some or undermine scaling positive outcomes.”
BackgroundAakhus, E., Granlund, I., Odgaard‐Jensen, J., Oxman, A. D., & Flottorp, S. A. (2015) · Implementation Science · doi:10.1186/s13012-016-0397-3 · Cited by 41 · see citing works
“Baker and colleagues [12] reviewed 32 studies to assess the effectiveness of tailored implementation interventions.”
BackgroundInfluentialSelf-citationGold, R. B., Bunce, A., Cottrell, E., Marino, M., Middendorf, M., Cowburn, S., Wright, D. A., Mossman, N., Dambrun, K., Powell, B. J., et al. (2019) · Implementation Science · doi:10.1186/s13012-019-0855-9 · Cited by 40 · see citing works
Vratsistas‐Curto, A., McCluskey, A., & Schurr, K. (2017) · BMJ Open Quality · doi:10.1136/bmjoq-2017-000212 · Cited by 42 · see citing works
“best approach is still not clear.(1) This study used the TDF and BCW as frameworks to identify, address and match identified barriers to appropriate behaviour change interventions.”
InfluentialCzosnek, L., Richards, J. A., Zopf, E. M., Cormie, P., Rosenbaum, S., & Rankin, N. M. (2021) · BMC Cancer · doi:10.1186/s12885-021-08196-7 · Cited by 42 · see citing works
“Further, evidence suggests implementation strategies, such as staff training, can increase the likelihood of successful implementation [86, 87].”
BackgroundBarakou, I., Hackett, K. L., Finch, T. L., & Hettinga, F. J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2270688 · Cited by 42 · see citing works
“The literature highlights the significance of selecting implementation intervention strategies that are tailored to address prevailing barriers [190–192].”
BackgroundHow is patient-centred care addressed in women’s health? A theoretical rapid review
Gagliardi, A. R., Dunn, S., Foster, A. M., Grace, S. L., Green, C. R., Khanlou, N., Miller, F. A., Stewart, D. E., Vigod, S. N., & Wright, F. C. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026121 · Cited by 40 · see citing works
“A Cochrane systematic review by Baker et al found that interventions that had been selected and tailored to address identified barriers of guideline-adherent clinical care were more likely to improve professional practice compared with either no intervention or simple dissemination of guidelines.(46) Therefore, in add…”
Result
- Authors
- Baker, R., Camosso-Stefinovic, J., Gillies, C., Shaw, E. J., Cheater, F., Flottorp, S., Robertson, N., Wensing, M., Fiander, M., Eccles, M. P., Godycki-Cwirko, M., van Lieshout, J., & Jäger, C.
- Affiliations
- University of Leicester (GB)
- Information Specialist, Consultant; Carl-Zeiss-Str. 37 Munich Bayern Germany D-85521
- National Institute for Health and Care Excellence (GB)
- University of East Anglia (GB)
- Nasjonalt Kunnskapssenter for Helsetjenesten (NO)
- Radboud University Medical Center (NL)
- Information Specialist, Consultant; Ottawa Ontario Canada
- Newcastle University (GB)
- Medical University of Lodz; Centre for Family and Community Medicine; Kopcindkiego 20 Lodz Poland 90-153
- Radboud University Medical Center; Scientific Institute for Quality of Healthcare; P.O.Box 9101 Nijmegen Netherlands 6500 HB
- University Hospital Heidelberg (DE)
- ORCID
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2015-04-29
- Volume
- 2015
- Issue
- 4
- Pages
- CD005470-CD005470
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC7271646
- OpenAlex
- W1579988526
- Semantic Scholar
- 52e02ec2b5cec8f59fbeeeed8279ed71182912ca
- Cited by
- 711
- References
- 222
- Citations by year
- 2026: 33 · 2025: 81 · 2024: 91 · 2023: 88 · 2022: 83 · 2021: 75 · 2020: 60 · 2019: 57 · 2018: 48 · 2017: 48 · 2016: 27 · 2015: 16 · 2013: 1 · 2012: 1
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Update notices
- new_version (2026-02-27)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
- Health Sciences › Health Professions › General Health Professions › Health Sciences Research and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- personalized interventions, implementation strategies, health care outcomes, theory-based intervention, risk of bias, nursing practice, primary care practices, quality improvement, meta-regression, risk of bias assessment, risk of bias adjustment
- MeSH terms
- Humans, Outcome and Process Assessment, Health Care, Professional Practice, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review